<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">psychiatry</journal-id><journal-title-group><journal-title xml:lang="ru">ПСИХИАТРИЯ</journal-title><trans-title-group xml:lang="en"><trans-title>Psychiatry (Moscow) (Psikhiatriya)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1683-8319</issn><issn pub-type="epub">2618-6667</issn><publisher><publisher-name>FSBSI “The Mental Health Research Centre”;   LLC «Publisher «MIA»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.30629/2618-6667-2023-21-7-46-64</article-id><article-id custom-type="elpub" pub-id-type="custom">psychiatry-1083</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НАУЧНЫЕ ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>SCIENTIFIC REVIEWS</subject></subj-group></article-categories><title-group><article-title>Прогениторы олигодендроцитов при шизофрении: патогенетическая роль и потенциальная мишень для терапии</article-title><trans-title-group xml:lang="en"><trans-title>Oligodendrocyte Progenitors in Schizophrenia: The Role in Pathogenesis and Potential Treatment Target</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3710-8456</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Коломеец</surname><given-names>Н. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kolomeets</surname><given-names>N. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Наталья Степановна Коломеец, доктор биологических наук, ведущий научный сотрудник, лаборатория клинической нейроморфологии</p><p>Москва</p></bio><bio xml:lang="en"><p>Natalya S. Kolomeets, Dr. of Sci. (Biol.), Leading Researcher, Laboratory of Neuropathology</p><p>Moscow</p></bio><email xlink:type="simple">ns-kolomeets@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Научный центр психического здоровья»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>FSBSI “Mental Health Research Centre”</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>31</day><month>01</month><year>2024</year></pub-date><volume>21</volume><issue>7</issue><fpage>46</fpage><lpage>64</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Коломеец Н.С., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Коломеец Н.С.</copyright-holder><copyright-holder xml:lang="en">Kolomeets N.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.journalpsychiatry.com/jour/article/view/1083">https://www.journalpsychiatry.com/jour/article/view/1083</self-uri><abstract><p>Обоснование: синдром нарушений межнейронных связей в мозге больных шизофренией тесно связан с выраженными нарушениями миелинизации в мозге пациентов, что подтверждается данными нейровизуалиционных исследований. Нарушения миелинизации мозга предполагают патологию клеток семейства олигодендроцитов (ОЛ). Особый интерес представляют прогениторы олигодендроцитов (ОП), осуществляющие миелинизацию аксонов в зрелом мозге на последних этапах дифференцировки. Цель обзора:  обобщить данные современных исследований, касающихся нарушений клеточного цикла семейства ОЛ при шизофрении и их возможных причин. Материалы и методы:  по ключевым словам «шизофрения, ОЛ, ОП», «ОП и гены риска шизофрении», «ОП и нейровоспаление», «ОП и антипсихотические препараты», «ОП, дофамин, серотонин» проведен поиск научных публикаций в базах MedLine/PubMed, Google Scholar, eLibrary. Для настоящего обзора отобрано 164 статьи, касающиеся связи перечисленных факторов с нарушениями дифференцировки ОП. Заключение:  для аутопсийного мозга пациентов характерен дефицит всех клеток семейства ОЛ, а также изменения корреляционных взаимосвязей между числом этих клеток, что может свидетельствовать о нарушениях дифференцировки ОП. Олигодендроцит- и миелин-связанные гены повышенного риска шизофрении играют значимую роль в регуляции дифференцировки ОП. В условиях нейровоспаления — важной составляющей патогенеза шизофрении — провоспалительные цитокины и активированная микроглия способны существенно влиять на пролиферацию и дифференцировку ОП. Атипичные нейролептики могут корректировать нарушения клеточного цикла семейства ОЛ и влиять на выраженность воспалительного процесса в мозге. Известно, что как ОЛ и ОП, так и микроглия и периферические иммунные клетки экспрессируют рецепторы дофамина и серотонина, основных мишеней этих препаратов. Патология ОП, тесно связанная с другими механизмами в патогенезе при шизофрении, рассматривается в качестве перспективной мишени для разработки новых подходов к фармакотерапии заболевания.</p></abstract><trans-abstract xml:lang="en"><p>Background:  schizophrenia is considered as a dysconnectivity disorder supported by neuroimaging studies have revealed altered myelination of white and grey matter. Altered myelination suggests oligodendrocyte (OL) family pathology. Oligodendrocyte progenitors (OP) are of special interest since they myelinate axons in mature brain at the last stage of the differentiation. The aim of review  —  to summarize modern research data concerning altered cell cycle of OL family in schizophrenia and their plausible reason. Material and methods: using the keywords “schizophrenia, OL, OP”, “OP and schizophrenia risk genes”, “OP and neuroinflamation”, “OP and antipsychotic drugs”, “OP, dopamine, serotonin” 164 studies concerning the influence of listed above factors on OP differentiation were selected the MedLine/PubMed, Google Scholar, eLibrary databases for analysis.  Conclusion: postmortem studies demonstrated essential deficit of OL family cells as well as altered correlation pattern between the number of these cells suggested altered OP differentiation. Some of OL and myelin-related gene variants caused higher schizophrenia risk play a critical role in OP differentiation. While neuroinflammation is important component of schizophrenia brain pathology proinflammatory cytokines and activated microglia exert substantial influence on OP proliferation and differentiation. Atypical antipsychotics are able to correct OP maturation and have anti-inflammatory effects. OL and OP as well as microglia and peripheral immune cells express dopamine and serotonin receptors, main  therapeutic targets of these drugs. OP pathology as important component of schizophrenia  pathogenesis, tightly linked with another abnormalities, and considers as promising target for future therapeutic strategy.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>шизофрения</kwd><kwd>олигодендроциты</kwd><kwd>прогениторы олигодендроцитов</kwd><kwd>миелин- и олигодендроцит-связанные гены риска шизофрении</kwd><kwd>нейровоспаление</kwd><kwd>атипичные антипсихотические препараты</kwd><kwd>нейромедиаторы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>schizophrenia</kwd><kwd>oligodendrocyte</kwd><kwd>oligodendrocyte progenitors</kwd><kwd>OL- and myelin-related risk genes</kwd><kwd>neuroinflamation</kwd><kwd>atypical antipsychotics</kwd><kwd>neurotransmitters</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Schmitt A, Hasan A, Gruber O, Falkai P. Schizophrenia as a disorder of disconnectivity. Eur Arch Psychiatry Clin Neurosci. 2011;261(2):150–154. doi: 10.1007/s00406-011-0242-2</mixed-citation><mixed-citation xml:lang="en">Schmitt A, Hasan A, Gruber O, Falkai P. Schizophrenia as a disorder of disconnectivity. Eur Arch Psychiatry Clin Neurosci. 2011;261(2):150–154. doi: 10.1007/s00406-011-0242-2</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Koshiyama D, Fukunaga M, Okada N, Morita K, Nemoto K, Usui K, Yamamori H, Yasuda Y, Fujimoto M, Kudo N, Azechi H, Watanabe Y, Hashimoto N, Narita H, Kusumi I, Ohi K, Shimada T, Kataoka Y, Yamamoto M, Ozaki N, Okada G, Okamoto Y, Harada K, Matsuo K, Yamasue H, Abe O, Hashimoto R, Takahashi T, Hori T, Nakataki M, Onitsuka T, Holleran L, Jahanshad N, van Erp TGM, Turner J, Donohoe G, Thompson PM, Kasai K, Hashimoto R; COCORO. White matter microstructural alterations across four major psychiatric disorders: megaanalysis study in 2937 individuals. Mol Psychiatry . 2020;25(4):883–895. doi: 10.1038/s41380-019-0553-7 Epub 2019 Nov 29. PMID: 31780770; PMCID: PMC7156346.</mixed-citation><mixed-citation xml:lang="en">Koshiyama D, Fukunaga M, Okada N, Morita K, Nemoto K, Usui K, Yamamori H, Yasuda Y, Fujimoto M, Kudo N, Azechi H, Watanabe Y, Hashimoto N, Narita H, Kusumi I, Ohi K, Shimada T, Kataoka Y, Yamamoto M, Ozaki N, Okada G, Okamoto Y, Harada K, Matsuo K, Yamasue H, Abe O, Hashimoto R, Takahashi T, Hori T, Nakataki M, Onitsuka T, Holleran L, Jahanshad N, van Erp TGM, Turner J, Donohoe G, Thompson PM, Kasai K, Hashimoto R; COCORO. White matter microstructural alterations across four major psychiatric disorders: megaanalysis study in 2937 individuals. Mol Psychiatry . 2020;25(4):883–895. doi: 10.1038/s41380-019-0553-7 Epub 2019 Nov 29. PMID: 31780770; PMCID: PMC7156346.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Bells S, Lefebvre J, Longoni G, Narayanan S, Arnold DL, Yeh EA, Mabbott DJ. White matter plasticity and maturation in human cognition. Glia. 2019;67(11):2020– 2037. doi: 10.1002/glia.23661</mixed-citation><mixed-citation xml:lang="en">Bells S, Lefebvre J, Longoni G, Narayanan S, Arnold DL, Yeh EA, Mabbott DJ. White matter plasticity and maturation in human cognition. Glia. 2019;67(11):2020– 2037. doi: 10.1002/glia.23661</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Fields RD, Araque A, Johansen-Berg H, Lim SS, Lynch G, Nave KA, Nedergaard M, Perez R, Sejnowski T, Wake H. Glial biology in learning and cognition. Neuroscientist. 2014;20(5):426–431. doi: 10.1177/1073858413504465 Epub 2013 Oct 11. PMID: 24122821; PMCID: PMC4161624.</mixed-citation><mixed-citation xml:lang="en">Fields RD, Araque A, Johansen-Berg H, Lim SS, Lynch G, Nave KA, Nedergaard M, Perez R, Sejnowski T, Wake H. Glial biology in learning and cognition. Neuroscientist. 2014;20(5):426–431. doi: 10.1177/1073858413504465 Epub 2013 Oct 11. PMID: 24122821; PMCID: PMC4161624.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Bartzokis G. Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments. Neuropharmacology . 2012;62(7):2137–2153. doi: 10.1016/j.neuropharm.2012.01.015</mixed-citation><mixed-citation xml:lang="en">Bartzokis G. Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments. Neuropharmacology . 2012;62(7):2137–2153. doi: 10.1016/j.neuropharm.2012.01.015</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Huntenburg JM, Bazin PL, Goulas A, Tardif CL, Villringer A, Margulies DS. A Systematic Relationship Between Functional Connectivity and Intracortical Myelin in the Human Cerebral Cortex. Cereb Cortex. 2017;27(2):981–997. doi: 10.1093/cercor/bhx030</mixed-citation><mixed-citation xml:lang="en">Huntenburg JM, Bazin PL, Goulas A, Tardif CL, Villringer A, Margulies DS. A Systematic Relationship Between Functional Connectivity and Intracortical Myelin in the Human Cerebral Cortex. Cereb Cortex. 2017;27(2):981–997. doi: 10.1093/cercor/bhx030</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Forkel SJ, Friedrich P, Thiebaut de Schotten M, Howells H. White matter variability, cognition, and disorders: a systematic review. Brain Struct Funct. 2022;227(2):529–544. doi: 10.1007/s00429-021-02382-w</mixed-citation><mixed-citation xml:lang="en">Forkel SJ, Friedrich P, Thiebaut de Schotten M, Howells H. White matter variability, cognition, and disorders: a systematic review. Brain Struct Funct. 2022;227(2):529–544. doi: 10.1007/s00429-021-02382-w</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Sakurai T, Gamo NJ, Hikida T, Kim SH, Murai T, Tomoda T, Sawa A. Converging models of schizophrenia — Network alterations of prefrontal cortex underlying cognitive impairments. Prog Neurobiol . 2015;134:178– 201. doi: 10.1016/j.pneurobio.2015.09.010</mixed-citation><mixed-citation xml:lang="en">Sakurai T, Gamo NJ, Hikida T, Kim SH, Murai T, Tomoda T, Sawa A. Converging models of schizophrenia — Network alterations of prefrontal cortex underlying cognitive impairments. Prog Neurobiol . 2015;134:178– 201. doi: 10.1016/j.pneurobio.2015.09.010</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Whitfield-Gabrieli S, Ford JM. Default mode network activity and connectivity in psychopathology. Annu Rev Clin Psychol . 2012;8:49–76. doi: 10.1146/an-nurev-clinpsy-032511-143049</mixed-citation><mixed-citation xml:lang="en">Whitfield-Gabrieli S, Ford JM. Default mode network activity and connectivity in psychopathology. Annu Rev Clin Psychol . 2012;8:49–76. doi: 10.1146/an-nurev-clinpsy-032511-143049</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Suminaite D, Lyons DA, Livesey MR. Myelinated axon physiology and regulation of neural circuit function. Glia . 2019;67(11):2050–2062. doi: 10.1002/glia.23665</mixed-citation><mixed-citation xml:lang="en">Suminaite D, Lyons DA, Livesey MR. Myelinated axon physiology and regulation of neural circuit function. Glia . 2019;67(11):2050–2062. doi: 10.1002/glia.23665</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Takahashi N, Sakurai T, Davis KL, Buxbaum JD. Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia. Prog Neurobiol. 2011;93(1):13–24. doi: 10.1016/j.pneuro-bio.2010.09.004</mixed-citation><mixed-citation xml:lang="en">Takahashi N, Sakurai T, Davis KL, Buxbaum JD. Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia. Prog Neurobiol. 2011;93(1):13–24. doi: 10.1016/j.pneuro-bio.2010.09.004</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Stephan KE, Friston KJ, Frith CD. Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring. Schizophr Bull. 2009;35(3):509–527. doi: 10.1093/schbul/sbn176</mixed-citation><mixed-citation xml:lang="en">Stephan KE, Friston KJ, Frith CD. Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring. Schizophr Bull. 2009;35(3):509–527. doi: 10.1093/schbul/sbn176</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Tanaka H, Ma J, Tanaka KF, Takao K, Komada M, Tanda K, Suzuki A, Ishibashi T, Baba H, Isa T, Shigemoto R, Ono K, Miyakawa T, Ikenaka K. Mice with altered myelin proteolipid protein gene expression display cognitive deficits accompanied by abnormal neuronglia interactions and decreased conduction velocities. J Neurosci. 2009;29(26):8363–8371. doi: 10.1523/JNEUROSCI.3216-08.2009</mixed-citation><mixed-citation xml:lang="en">Tanaka H, Ma J, Tanaka KF, Takao K, Komada M, Tanda K, Suzuki A, Ishibashi T, Baba H, Isa T, Shigemoto R, Ono K, Miyakawa T, Ikenaka K. Mice with altered myelin proteolipid protein gene expression display cognitive deficits accompanied by abnormal neuronglia interactions and decreased conduction velocities. J Neurosci. 2009;29(26):8363–8371. doi: 10.1523/JNEUROSCI.3216-08.2009</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Dawson MR, Polito A, Levine JM, Reynolds R. NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS. Mol Cell Neurosci. 2003;24(2):476–488. doi: 10.1016/s1044-7431(03)00210-0</mixed-citation><mixed-citation xml:lang="en">Dawson MR, Polito A, Levine JM, Reynolds R. NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS. Mol Cell Neurosci. 2003;24(2):476–488. doi: 10.1016/s1044-7431(03)00210-0</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Fekete CD, Nishiyama A. Presentation and integration of multiple signals that modulate oligodendrocyte lineage progression and myelination. Front Cell Neurosci. 2022;16:1041853. doi: 10.3389/fn-cel.2022.1041853</mixed-citation><mixed-citation xml:lang="en">Fekete CD, Nishiyama A. Presentation and integration of multiple signals that modulate oligodendrocyte lineage progression and myelination. Front Cell Neurosci. 2022;16:1041853. doi: 10.3389/fn-cel.2022.1041853</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu X , Hill RA, Dietr ich D, Komitova M, Suzuki R, Nishiyama A. Age-dependent fate and lineage restriction of single NG2 cells. Development. 2011;138(4):745– 753. doi: 10.1242/dev.047951</mixed-citation><mixed-citation xml:lang="en">Zhu X , Hill RA, Dietr ich D, Komitova M, Suzuki R, Nishiyama A. Age-dependent fate and lineage restriction of single NG2 cells. Development. 2011;138(4):745– 753. doi: 10.1242/dev.047951</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Kang SH, Fukaya M, Yang JK, Rothstein JD, Bergles DE. NG2 + CNS glial progenitors remain committed to the oligodendrocyte lineage in post-natal life and following neurodegeneration. Neuron . 2010;68(4):668–681. doi: 10.1016/j.neuron.2010.09.009</mixed-citation><mixed-citation xml:lang="en">Kang SH, Fukaya M, Yang JK, Rothstein JD, Bergles DE. NG2 + CNS glial progenitors remain committed to the oligodendrocyte lineage in post-natal life and following neurodegeneration. Neuron . 2010;68(4):668–681. doi: 10.1016/j.neuron.2010.09.009</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Bergles DE, Richardson WD. Oligodendrocyte Development and Plasticity. Cold Spring Harb Perspect Biol . 2015;8(2):a020453. doi: 10.1101/cshperspect.a020453</mixed-citation><mixed-citation xml:lang="en">Bergles DE, Richardson WD. Oligodendrocyte Development and Plasticity. Cold Spring Harb Perspect Biol . 2015;8(2):a020453. doi: 10.1101/cshperspect.a020453</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Nagy B, Hovhannisyan A, Barzan R, Chen TJ, Kukley M. Different patterns of neuronal activity trigger distinct responses of oligodendrocyte precursor cells in the corpus callosum. PLoS Biol. 2017;15(8):e2001993. doi: 10.1371/journal.pbio.2001993</mixed-citation><mixed-citation xml:lang="en">Nagy B, Hovhannisyan A, Barzan R, Chen TJ, Kukley M. Different patterns of neuronal activity trigger distinct responses of oligodendrocyte precursor cells in the corpus callosum. PLoS Biol. 2017;15(8):e2001993. doi: 10.1371/journal.pbio.2001993</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Mitew S, Gobius I, Fenlon LR, McDougall SJ, Hawkes D, Xing YL, Bujalka H, Gundlach AL, Richards LJ, Kilpatrick TJ, Merson TD, Emery B. Pharmacogenetic stimulation of neuronal activity increases myelination in an axon-specific manner. Nat Commun . 2018;9(1):306. doi: 10.1038/s41467-017-02719-2</mixed-citation><mixed-citation xml:lang="en">Mitew S, Gobius I, Fenlon LR, McDougall SJ, Hawkes D, Xing YL, Bujalka H, Gundlach AL, Richards LJ, Kilpatrick TJ, Merson TD, Emery B. Pharmacogenetic stimulation of neuronal activity increases myelination in an axon-specific manner. Nat Commun . 2018;9(1):306. doi: 10.1038/s41467-017-02719-2</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Linneberg C, Toft CLF, Kjaer-Sorensen K, Laurs-en LS. L1cam-mediated developmental processes of the nervous system are differentially regulated by proteolytic processing. Sci Rep . 2019;9(1):3716. doi: 10.1038/s41598-019-39884-x</mixed-citation><mixed-citation xml:lang="en">Linneberg C, Toft CLF, Kjaer-Sorensen K, Laurs-en LS. L1cam-mediated developmental processes of the nervous system are differentially regulated by proteolytic processing. Sci Rep . 2019;9(1):3716. doi: 10.1038/s41598-019-39884-x</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Clayton BLJ, Paul J. Tesar PJ. Oligodendrocyte progenitor cell fate and function in development and disease. Curr Opin Cell Biol . 2021;73:35–40. doi: 10.1016/j.ceb.2021.05.003</mixed-citation><mixed-citation xml:lang="en">Clayton BLJ, Paul J. Tesar PJ. Oligodendrocyte progenitor cell fate and function in development and disease. Curr Opin Cell Biol . 2021;73:35–40. doi: 10.1016/j.ceb.2021.05.003</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Uranova NA, Vikhreva OV, Rakhmanova VI, Orlovskaya DD. Ultrastructural pathology of oligodendrocytes adjacent to microglia in prefrontal white matter in schizophrenia. NPJ Schizophr. 2018;4(1):26. doi: 10.1038/s41537-018-0068-2</mixed-citation><mixed-citation xml:lang="en">Uranova NA, Vikhreva OV, Rakhmanova VI, Orlovskaya DD. Ultrastructural pathology of oligodendrocytes adjacent to microglia in prefrontal white matter in schizophrenia. NPJ Schizophr. 2018;4(1):26. doi: 10.1038/s41537-018-0068-2</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Vikhreva OV, Rakhmanova VI, Orlovskaya DD, Uranova NA. Ultrastructural alterations of oligodendrocytes in prefrontal white matter in schizophrenia: A post-mortem morphometric study. Schizophr Res. 2016;177(1–3):28–36. doi: 10.1016/j.schres.2016.04.023</mixed-citation><mixed-citation xml:lang="en">Vikhreva OV, Rakhmanova VI, Orlovskaya DD, Uranova NA. Ultrastructural alterations of oligodendrocytes in prefrontal white matter in schizophrenia: A post-mortem morphometric study. Schizophr Res. 2016;177(1–3):28–36. doi: 10.1016/j.schres.2016.04.023</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Uranova NA, Vikhreva OV, Rachmanova VI, Orlovskaya DD. Ultrastructural alterations of myelinated fibers and oligodendrocytes in the prefrontal cortex in schizophrenia: a postmortem morphometric study. Schizophr Res Treatment . 2011;2011:325789. doi: 10.1155/2011/325789</mixed-citation><mixed-citation xml:lang="en">Uranova NA, Vikhreva OV, Rachmanova VI, Orlovskaya DD. Ultrastructural alterations of myelinated fibers and oligodendrocytes in the prefrontal cortex in schizophrenia: a postmortem morphometric study. Schizophr Res Treatment . 2011;2011:325789. doi: 10.1155/2011/325789</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Schmitt A, Tatsch L, Vollhardt A, Schneider-Axmann T, Raabe FJ, Roell L, Heinsen H, Hof PR, Falkai P, Schmitz C. Decreased Oligodendrocyte Number in Hippocampal Subfield CA4 in Schizophrenia: A Replication Study. Cells. 2022;11(20):3242. doi: 10.3390/cells11203242</mixed-citation><mixed-citation xml:lang="en">Schmitt A, Tatsch L, Vollhardt A, Schneider-Axmann T, Raabe FJ, Roell L, Heinsen H, Hof PR, Falkai P, Schmitz C. Decreased Oligodendrocyte Number in Hippocampal Subfield CA4 in Schizophrenia: A Replication Study. Cells. 2022;11(20):3242. doi: 10.3390/cells11203242</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Falkai P, Raabe F, Bogerts B, Schneider-Axmann T, Malchow B, Tatsch L, Huber V, Slapakova L, Dobrowolny H, Schmitz C, Cantuti-Castelvetri L, Simons M, Steiner J, Schmitt A. Association between altered hippocampal oligodendrocyte number and neuronal circuit structures in schizophrenia: a post-mortem analysis. Eur Arch Psychiatry Clin Neurosci. 2020;270(4):413–424. doi: 10.1007/s00406-019-01067-0</mixed-citation><mixed-citation xml:lang="en">Falkai P, Raabe F, Bogerts B, Schneider-Axmann T, Malchow B, Tatsch L, Huber V, Slapakova L, Dobrowolny H, Schmitz C, Cantuti-Castelvetri L, Simons M, Steiner J, Schmitt A. Association between altered hippocampal oligodendrocyte number and neuronal circuit structures in schizophrenia: a post-mortem analysis. Eur Arch Psychiatry Clin Neurosci. 2020;270(4):413–424. doi: 10.1007/s00406-019-01067-0</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Falkai P, Steiner J, Malchow B, Shariati J, Knaus A, Bernstein HG, Schneider-Axmann T, Kraus T, Hasan A, Bogerts B, Schmitt A. Oligodendrocyte and Interneuron Density in Hippocampal Subfields in Schizophrenia and Association of Oligodendrocyte Number with Cognitive Deficits. Front Cell Neurosci . 2016;10:78. doi: 10.3389/fncel.2016.00078</mixed-citation><mixed-citation xml:lang="en">Falkai P, Steiner J, Malchow B, Shariati J, Knaus A, Bernstein HG, Schneider-Axmann T, Kraus T, Hasan A, Bogerts B, Schmitt A. Oligodendrocyte and Interneuron Density in Hippocampal Subfields in Schizophrenia and Association of Oligodendrocyte Number with Cognitive Deficits. Front Cell Neurosci . 2016;10:78. doi: 10.3389/fncel.2016.00078</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Востриков ВМ, Уранова НА, Рахманова ВИ, Орловская ДД. Сниженная численная плотность олигодендроглиоцитов в префронтальной коре при шизофрении. Журнал неврологии и психиатрии имени С.С. Корсакова. 2004;104(1):47–51.</mixed-citation><mixed-citation xml:lang="en">Vostrikov VM, Uranova NA, Rakhmanova VI, Orlovskaia DD. Lowered oligodendroglial cell density inthe prefrontal cortex in schizophrenia. Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova. 2004;104(1):47–51. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Segal D, Schmitz C, Hof PR. Spatial distribution and density of oligodendrocytes in the cingulum bundle are unaltered in schizophrenia. Acta Neuropathol. 2009;117(4):385–394. doi: 10.1007/s00401-008-0379-x</mixed-citation><mixed-citation xml:lang="en">Segal D, Schmitz C, Hof PR. Spatial distribution and density of oligodendrocytes in the cingulum bundle are unaltered in schizophrenia. Acta Neuropathol. 2009;117(4):385–394. doi: 10.1007/s00401-008-0379-x</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Szuchet S, Nielsen JA, Lovas G, Domowicz MS, de Velasco JM, Maric D, Hudson LD. The genetic signature of perineuronal oligodendrocytes reveals their unique phenotype. Eur J Neurosci. 2011;34(12):1906–1922. doi: 10.1111/j.1460-9568.2011.07922.x</mixed-citation><mixed-citation xml:lang="en">Szuchet S, Nielsen JA, Lovas G, Domowicz MS, de Velasco JM, Maric D, Hudson LD. The genetic signature of perineuronal oligodendrocytes reveals their unique phenotype. Eur J Neurosci. 2011;34(12):1906–1922. doi: 10.1111/j.1460-9568.2011.07922.x</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Battefeld A, Klooster J, Kole MH. Myelinating satellite oligodendrocytes are integrated in a glial syncytium constraining neuronal high-frequency activity. Nat Commun. 2016;7:11298. doi: 10.1038/ncomms11298</mixed-citation><mixed-citation xml:lang="en">Battefeld A, Klooster J, Kole MH. Myelinating satellite oligodendrocytes are integrated in a glial syncytium constraining neuronal high-frequency activity. Nat Commun. 2016;7:11298. doi: 10.1038/ncomms11298</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Kolomeets NS, Uranova NA. Reduced oligodendrocyte density in layer 5 of the prefrontal cortex in schizophrenia. Eur Arch Psychiatry Clin Neurosci . 2018;23:1– 8. doi: 10.1007/s00406-018-0888-0</mixed-citation><mixed-citation xml:lang="en">Kolomeets NS, Uranova NA. Reduced oligodendrocyte density in layer 5 of the prefrontal cortex in schizophrenia. Eur Arch Psychiatry Clin Neurosci . 2018;23:1– 8. doi: 10.1007/s00406-018-0888-0</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Коломеец НС, Востриков ВМ. Нарушения кластеризации олигодендроцитов в супра- и инфрагранулярных слоях поля 10 префронтальной коры при шизофрении. Журнал неврологии и психиатрии имени С.С. Корсакова . 2019;119(12):62–68. doi: 10.17116/jnevro201911912162</mixed-citation><mixed-citation xml:lang="en">Kolomeets NS, Vostrikov VM. Abnormalities of oligodendrocyte clusters in supra- and infragranular layers of the prefrontal cortex in schizophrenia S.S. Korsakov Journal of Neurology and Psychiatry/ Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2019;119(12):62–68. (In Russ.). doi: 10.17116/jnev-ro201911912162</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Kolomeets NS, Uranova NA. Reduced number of satellite oligodendrocytes of pyramidal neurons in layer 5 of the prefrontal cortex in schizophrenia. Eur Arch Psychiatry Clin Neurosci . 2021;272(6):947–955. doi: 10.1007/s00406-021-01353-w</mixed-citation><mixed-citation xml:lang="en">Kolomeets NS, Uranova NA. Reduced number of satellite oligodendrocytes of pyramidal neurons in layer 5 of the prefrontal cortex in schizophrenia. Eur Arch Psychiatry Clin Neurosci . 2021;272(6):947–955. doi: 10.1007/s00406-021-01353-w</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Kolomeets NS, Vostrikov VM, Uranova NA. Abnormalities in oligodendrocyte clusters in the inferior parietal cortex in schizophrenia are associated with insight. Eur J Psychiat . 2013;27(4):24 8–258. doi: 10.4321/S0213-61632013000400003</mixed-citation><mixed-citation xml:lang="en">Kolomeets NS, Vostrikov VM, Uranova NA. Abnormalities in oligodendrocyte clusters in the inferior parietal cortex in schizophrenia are associated with insight. Eur J Psychiat . 2013;27(4):24 8–258. doi: 10.4321/S0213-61632013000400003</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Uranova NA, Vostrikov VM, Kolomeets NS. Oligodendrocyte abnormalities in layer 5 in the inferior parietal lobule are associated with lack of insight: a postmortem morphometric study. Eur J Psychiat. 2015;29(3):215–222. doi: 10.4321/S0213-61632015000300006</mixed-citation><mixed-citation xml:lang="en">Uranova NA, Vostrikov VM, Kolomeets NS. Oligodendrocyte abnormalities in layer 5 in the inferior parietal lobule are associated with lack of insight: a postmortem morphometric study. Eur J Psychiat. 2015;29(3):215–222. doi: 10.4321/S0213-61632015000300006</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Vostrikov VM, Kolomeets NS, Uranova NA. Deficit of perineuronal oligodendrocytes in the inferior parietal lobule is associated with lack of insight in schizophrenia. Eur J Psychiat . 2014;28(2):114–123. doi: 10.4321/S0213-61632014000200005</mixed-citation><mixed-citation xml:lang="en">Vostrikov VM, Kolomeets NS, Uranova NA. Deficit of perineuronal oligodendrocytes in the inferior parietal lobule is associated with lack of insight in schizophrenia. Eur J Psychiat . 2014;28(2):114–123. doi: 10.4321/S0213-61632014000200005</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">van den Heuvel MP, Fornito A. Brain networks in schizophrenia . Neuropsychol Rev . 2014;24(1):32–48. doi: 10.1007/s11065-014-9248-7</mixed-citation><mixed-citation xml:lang="en">van den Heuvel MP, Fornito A. Brain networks in schizophrenia . Neuropsychol Rev . 2014;24(1):32–48. doi: 10.1007/s11065-014-9248-7</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Chahine G, Richter A, Wolter S, Goya-Maldonado R, Gruber O. Disruptions in the left frontoparietal network underlie resting state endophenotypic markers in schizophrenia. Hum Brain Mapp. 2017;38(4):1741– 1750. doi: 10.1002/hbm.23477</mixed-citation><mixed-citation xml:lang="en">Chahine G, Richter A, Wolter S, Goya-Maldonado R, Gruber O. Disruptions in the left frontoparietal network underlie resting state endophenotypic markers in schizophrenia. Hum Brain Mapp. 2017;38(4):1741– 1750. doi: 10.1002/hbm.23477</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Liu X, Zhuo C, Qin W, Zhu J, Xu L, Xu Y, Yu C. Selective functional connectivity abnormality of the transition zone of the inferior parietal lobule in schizophrenia. Neuroimage Clin . 2016;11:789–795. doi: 10.1016/j.nicl.2016.05.021</mixed-citation><mixed-citation xml:lang="en">Liu X, Zhuo C, Qin W, Zhu J, Xu L, Xu Y, Yu C. Selective functional connectivity abnormality of the transition zone of the inferior parietal lobule in schizophrenia. Neuroimage Clin . 2016;11:789–795. doi: 10.1016/j.nicl.2016.05.021</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Wei W, Zhang Y, Li Y, Meng Y, Li M, Wang Q, Deng W, Ma X, Palaniyappan L, Zhang N, Li T. Depth-dependent abnormal cortical myelination in first-episode treatment-naïve schizophrenia. Hum Brain Mapp. 2020;41(10):2782–2793. doi: 10.1002/hbm.24977</mixed-citation><mixed-citation xml:lang="en">Wei W, Zhang Y, Li Y, Meng Y, Li M, Wang Q, Deng W, Ma X, Palaniyappan L, Zhang N, Li T. Depth-dependent abnormal cortical myelination in first-episode treatment-naïve schizophrenia. Hum Brain Mapp. 2020;41(10):2782–2793. doi: 10.1002/hbm.24977</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Vartanian O, Beatty EL, Smith I, Blackler K, Lam Q, Forbes S. One-way traffic: The inferior frontal gyrus controls brain activation in the middle temporal gyrus and inferior parietal lobule during divergent thinking. Neuropsychologia. 2018;118:68–78. doi: 10.1016/j.neuropsychologia.2018.02.024</mixed-citation><mixed-citation xml:lang="en">Vartanian O, Beatty EL, Smith I, Blackler K, Lam Q, Forbes S. One-way traffic: The inferior frontal gyrus controls brain activation in the middle temporal gyrus and inferior parietal lobule during divergent thinking. Neuropsychologia. 2018;118:68–78. doi: 10.1016/j.neuropsychologia.2018.02.024</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Price CJ. The anatomy of language: contributions from functional neuroimaging. J Anat. 2000;197 Pt 3(Pt 3):335–359. doi: 10.1046/j.1469-7580.2000.19730335.x</mixed-citation><mixed-citation xml:lang="en">Price CJ. The anatomy of language: contributions from functional neuroimaging. J Anat. 2000;197 Pt 3(Pt 3):335–359. doi: 10.1046/j.1469-7580.2000.19730335.x</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Cunningham SI, Tomasi D, Volkow ND. Structural and functional connectivity of the precuneus and thalamus to the default mode network. Hum Brain Mapp. 2017;38(2):938–956. doi: 10.1002/hbm.23429</mixed-citation><mixed-citation xml:lang="en">Cunningham SI, Tomasi D, Volkow ND. Structural and functional connectivity of the precuneus and thalamus to the default mode network. Hum Brain Mapp. 2017;38(2):938–956. doi: 10.1002/hbm.23429</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Humphreys GF, Lambon Ralph MA. Fusion and Fission of Cognitive Functions in the Human Parietal Cortex. Cereb Cortex . 2015;25(10):3547–3560. doi: 10.1093/cercor/bhu198</mixed-citation><mixed-citation xml:lang="en">Humphreys GF, Lambon Ralph MA. Fusion and Fission of Cognitive Functions in the Human Parietal Cortex. Cereb Cortex . 2015;25(10):3547–3560. doi: 10.1093/cercor/bhu198</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">van Kemenade BM, Arikan BE, Kircher T, Straube B. The angular gyrus is a supramodal comparator area in action-outcome monitoring. Brain Struct Funct. 2017;222(8):3691–3703. doi: 10.1007/s00429-017-1428-9</mixed-citation><mixed-citation xml:lang="en">van Kemenade BM, Arikan BE, Kircher T, Straube B. The angular gyrus is a supramodal comparator area in action-outcome monitoring. Brain Struct Funct. 2017;222(8):3691–3703. doi: 10.1007/s00429-017-1428-9</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Hilgetag CC, Grant S. Uniformity, specificity and variability of corticocortical connectivity. Philos Trans R Soc Lond B Biol Sci . 2000;355(1393):7–20. doi: 10.1098/rstb.2000.0546</mixed-citation><mixed-citation xml:lang="en">Hilgetag CC, Grant S. Uniformity, specificity and variability of corticocortical connectivity. Philos Trans R Soc Lond B Biol Sci . 2000;355(1393):7–20. doi: 10.1098/rstb.2000.0546</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Theyel BB, Llano DA, Sherman SM. The corticothal-amocortical circuit drives higher-order cortex in the mouse. Nat Neurosci . 2010;13(1):84–88. doi: 10.1038/nn.2449</mixed-citation><mixed-citation xml:lang="en">Theyel BB, Llano DA, Sherman SM. The corticothal-amocortical circuit drives higher-order cortex in the mouse. Nat Neurosci . 2010;13(1):84–88. doi: 10.1038/nn.2449</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Sherman SM, Guillery RW. Distinct functions for direct and transthalamic corticocortical connections. J Neurophysiol. 2011;106(3):1068–1077. doi: 10.1152/jn.00429.2011 Epub 2011 Jun 15. PMID: 21676936.</mixed-citation><mixed-citation xml:lang="en">Sherman SM, Guillery RW. Distinct functions for direct and transthalamic corticocortical connections. J Neurophysiol. 2011;106(3):1068–1077. doi: 10.1152/jn.00429.2011 Epub 2011 Jun 15. PMID: 21676936.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Micheva KD, Wolman D, Mensh BD, Pax E, Buchanan J, Smith SJ, Bock DD. A large fraction of neocortical myelin ensheathes axons of local inhibitory neurons. Elife. 2016;5:e15784. doi: 10.7554/eLife.15784</mixed-citation><mixed-citation xml:lang="en">Micheva KD, Wolman D, Mensh BD, Pax E, Buchanan J, Smith SJ, Bock DD. A large fraction of neocortical myelin ensheathes axons of local inhibitory neurons. Elife. 2016;5:e15784. doi: 10.7554/eLife.15784</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Yao B, Neggers SFW, Kahn RS, Thakkar KN. Altered thalamocortical structural connectivity in persons with schizophrenia and healthy siblings. Neuroimage Clin. 2020;28:102370. doi: 10.1016/j.nicl.2020.102370</mixed-citation><mixed-citation xml:lang="en">Yao B, Neggers SFW, Kahn RS, Thakkar KN. Altered thalamocortical structural connectivity in persons with schizophrenia and healthy siblings. Neuroimage Clin. 2020;28:102370. doi: 10.1016/j.nicl.2020.102370</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Roussos P, Haroutunian V. Schizophrenia: susceptibility genes and oligodendroglial and myelin related abnormalities. Front Cell Neurosci . 2014;8:5. doi: 10.3389/fncel.2014.00005</mixed-citation><mixed-citation xml:lang="en">Roussos P, Haroutunian V. Schizophrenia: susceptibility genes and oligodendroglial and myelin related abnormalities. Front Cell Neurosci . 2014;8:5. doi: 10.3389/fncel.2014.00005</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Georgieva L, Moskvina V, Peirce T, Norton N, Bray NJ, Jones L, Holmans P, Macgregor S, Zammit S, Wilkinson J, Williams H, Nikolov I, Williams N, Ivanov D, Davis KL, Haroutunian V, Buxbaum JD, Craddock N, Kirov G, Owen MJ, O’Donovan MC. Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia. Proc Natl Acad Sci USA. 2006;103(33):12469–12474. doi: 10.1073/pnas.0603029103</mixed-citation><mixed-citation xml:lang="en">Georgieva L, Moskvina V, Peirce T, Norton N, Bray NJ, Jones L, Holmans P, Macgregor S, Zammit S, Wilkinson J, Williams H, Nikolov I, Williams N, Ivanov D, Davis KL, Haroutunian V, Buxbaum JD, Craddock N, Kirov G, Owen MJ, O’Donovan MC. Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia. Proc Natl Acad Sci USA. 2006;103(33):12469–12474. doi: 10.1073/pnas.0603029103</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Komatsu H, Takeuchi H, Kikuchi Y, Ono C, Yu Z, Iizuka K, Takano Y, Kakuto Y, Funakoshi S, Ono T, Ito J, Kunii Y, Hino M, Nagaoka A, Iwasaki Y, Yamamori H, Yasuda Y, Fujimoto M, Azechi H, Kudo N, Hashimoto R, Yabe H, Yoshida M, Saito Y, Kakita A, Fuse N, Kawashima R, Taki Y, Tomita H. Ethnicity-Dependent Effects of Schizophrenia Risk Variants of the OLIG2 Gene on OLIG2 Transcription and White Matter Integrity. Schizophr Bull . 2020;46(6):1619–1628. doi: 10.1093/schbul/sbaa049</mixed-citation><mixed-citation xml:lang="en">Komatsu H, Takeuchi H, Kikuchi Y, Ono C, Yu Z, Iizuka K, Takano Y, Kakuto Y, Funakoshi S, Ono T, Ito J, Kunii Y, Hino M, Nagaoka A, Iwasaki Y, Yamamori H, Yasuda Y, Fujimoto M, Azechi H, Kudo N, Hashimoto R, Yabe H, Yoshida M, Saito Y, Kakita A, Fuse N, Kawashima R, Taki Y, Tomita H. Ethnicity-Dependent Effects of Schizophrenia Risk Variants of the OLIG2 Gene on OLIG2 Transcription and White Matter Integrity. Schizophr Bull . 2020;46(6):1619–1628. doi: 10.1093/schbul/sbaa049</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Chubb JE, Bradshaw NJ, Soares DC, Porteous DJ, Millar JK. The DISC locus in psychiatric illness. Mol Psychiatry. 2008;13(1):36–64. doi: 10.1038/sj.mp.4002106</mixed-citation><mixed-citation xml:lang="en">Chubb JE, Bradshaw NJ, Soares DC, Porteous DJ, Millar JK. The DISC locus in psychiatric illness. Mol Psychiatry. 2008;13(1):36–64. doi: 10.1038/sj.mp.4002106</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Hattori T, Shimizu S, Koyama Y, Emoto H, Matsumoto Y, Kumamoto N, Yamada K, Takamura H, Matsuzaki S, Katayama T, Tohyama M, Ito A. DISC1 (disrupted-in-schizophrenia-1) regulates differentiation of oligodendrocytes. PLoS One. 2014;9(2):e88506. doi: 10.1371/journal.pone.0088506</mixed-citation><mixed-citation xml:lang="en">Hattori T, Shimizu S, Koyama Y, Emoto H, Matsumoto Y, Kumamoto N, Yamada K, Takamura H, Matsuzaki S, Katayama T, Tohyama M, Ito A. DISC1 (disrupted-in-schizophrenia-1) regulates differentiation of oligodendrocytes. PLoS One. 2014;9(2):e88506. doi: 10.1371/journal.pone.0088506</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Bernstein HG, Jauch E, Dobrowolny H, Mawrin C, Steiner J, Bogerts B. Increased density of DISC1-immunoreactive oligodendroglial cells in fronto-parietal white matter of patients with paranoid schizophrenia. Eur Arch Psychiatry Clin Neurosci . 2016;266(6):495–504. doi: 10.1007/s00406-015-0640-y Epub 2015 Aug 28. PMID: 26315603.</mixed-citation><mixed-citation xml:lang="en">Bernstein HG, Jauch E, Dobrowolny H, Mawrin C, Steiner J, Bogerts B. Increased density of DISC1-immunoreactive oligodendroglial cells in fronto-parietal white matter of patients with paranoid schizophrenia. Eur Arch Psychiatry Clin Neurosci . 2016;266(6):495–504. doi: 10.1007/s00406-015-0640-y Epub 2015 Aug 28. PMID: 26315603.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Millar JK. Disruption of two novel genes by a trans-location co-segregating with schizophrenia. Hum Mol Genet. 2000;9:1415–1423. doi: 10.1093/hmg/9.9.1415</mixed-citation><mixed-citation xml:lang="en">Millar JK. Disruption of two novel genes by a trans-location co-segregating with schizophrenia. Hum Mol Genet. 2000;9:1415–1423. doi: 10.1093/hmg/9.9.1415</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Yu G, Su Y, Guo C, Yi C, Yu B, Chen H, Cui Y, Wang X, Wang Y, Chen X, Wang S, Wang Q, Chen X, Hu X, Mei F, Verkhratsky A, Xiao L, Niu J. Pathological oligodendrocyte precursor cells revealed in human schizophrenic brains and trigger schizophrenia-like behaviors and synaptic defects in genetic animal model. Mol Psychiatry. 2022;27(12):5154–5166. doi: 10.1038/s41380-022-01777-3</mixed-citation><mixed-citation xml:lang="en">Yu G, Su Y, Guo C, Yi C, Yu B, Chen H, Cui Y, Wang X, Wang Y, Chen X, Wang S, Wang Q, Chen X, Hu X, Mei F, Verkhratsky A, Xiao L, Niu J. Pathological oligodendrocyte precursor cells revealed in human schizophrenic brains and trigger schizophrenia-like behaviors and synaptic defects in genetic animal model. Mol Psychiatry. 2022;27(12):5154–5166. doi: 10.1038/s41380-022-01777-3</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Shimizu S, Koyama Y, Hattori T, Tachibana T, Yoshimi T, Emoto H, Matsumoto Y, Miyata S, Katayama T, Ito A, Tohyama M. DBZ, a CNS-specific DISC1 binding protein, positively regulates oligodendrocyte differentiation. Glia. 2014;62(5):709–724. doi: 10.1002/glia.22636</mixed-citation><mixed-citation xml:lang="en">Shimizu S, Koyama Y, Hattori T, Tachibana T, Yoshimi T, Emoto H, Matsumoto Y, Miyata S, Katayama T, Ito A, Tohyama M. DBZ, a CNS-specific DISC1 binding protein, positively regulates oligodendrocyte differentiation. Glia. 2014;62(5):709–724. doi: 10.1002/glia.22636</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Yamamuro K, Kimoto S, Rosen KM, Kishimoto T, Makinodan M. Potential primary roles of glial cells in the mechanisms of psychiatric disorders. Front Cell Neurosci. 2015;9:154. doi: 10.3389/fncel.2015.00154</mixed-citation><mixed-citation xml:lang="en">Yamamuro K, Kimoto S, Rosen KM, Kishimoto T, Makinodan M. Potential primary roles of glial cells in the mechanisms of psychiatric disorders. Front Cell Neurosci. 2015;9:154. doi: 10.3389/fncel.2015.00154</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Anitha A, Nakamura K, Yamada K, Iwayama Y, Toyota T, Takei N, Iwata Y, Suzuki K, Sekine Y, Matsuzaki H, Kawai M, Thanseem I, Miyoshi K, Katayama T, Matsuzaki S, Baba K, Honda A, Hattori T, Shimizu S, Kumamoto N, Kikuchi M, Tohyama M, Yoshikawa T, Mori N. Association studies and gene expression analyses of the DISC1-interacting molecules, pericentrin 2 (PCNT2) and DISC1-binding zinc finger protein (DBZ), with schizophrenia and with bipolar disorder. Am J Med Genet B Neuropsychiatr Genet . 2009;150B(7):967–976. doi: 10.1002/ajmg.b.30926</mixed-citation><mixed-citation xml:lang="en">Anitha A, Nakamura K, Yamada K, Iwayama Y, Toyota T, Takei N, Iwata Y, Suzuki K, Sekine Y, Matsuzaki H, Kawai M, Thanseem I, Miyoshi K, Katayama T, Matsuzaki S, Baba K, Honda A, Hattori T, Shimizu S, Kumamoto N, Kikuchi M, Tohyama M, Yoshikawa T, Mori N. Association studies and gene expression analyses of the DISC1-interacting molecules, pericentrin 2 (PCNT2) and DISC1-binding zinc finger protein (DBZ), with schizophrenia and with bipolar disorder. Am J Med Genet B Neuropsychiatr Genet . 2009;150B(7):967–976. doi: 10.1002/ajmg.b.30926</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Nielsen JA, Hudson LD, Armstrong RC. Nuclear organization in differentiating oligodendrocytes. J Cell Sci. 2002;115:4071–4079. doi: 10.1242/jcs.00103</mixed-citation><mixed-citation xml:lang="en">Nielsen JA, Hudson LD, Armstrong RC. Nuclear organization in differentiating oligodendrocytes. J Cell Sci. 2002;115:4071–4079. doi: 10.1242/jcs.00103</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Li M, Xiao L, Chen X. Histone Acetylation and Methylation Underlie Oligodendroglial and Myelin Susceptibility in Schizophrenia. Front Cell Neurosci . 2022;16:823708. doi: 10.3389/fncel.2022.823708</mixed-citation><mixed-citation xml:lang="en">Li M, Xiao L, Chen X. Histone Acetylation and Methylation Underlie Oligodendroglial and Myelin Susceptibility in Schizophrenia. Front Cell Neurosci . 2022;16:823708. doi: 10.3389/fncel.2022.823708</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Chen X, Duan H, Xiao L, Gan J. Genetic and Epigenetic Alterations Underlie Oligodendroglia Susceptibility and White Matter Etiology in Psychiatric Disorders. Front Genet. 2018;9:565. doi: 10.3389/fgene.2018.00565</mixed-citation><mixed-citation xml:lang="en">Chen X, Duan H, Xiao L, Gan J. Genetic and Epigenetic Alterations Underlie Oligodendroglia Susceptibility and White Matter Etiology in Psychiatric Disorders. Front Genet. 2018;9:565. doi: 10.3389/fgene.2018.00565</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Solek CM, Farooqi N, Verly M, Lim TK, Ruthazer ES. Maternal immune activation in neurodevelopmental disorders. Developmental Dynamics . 2018;247(4):588– 619. doi: 10.1002/dvdy.24612</mixed-citation><mixed-citation xml:lang="en">Solek CM, Farooqi N, Verly M, Lim TK, Ruthazer ES. Maternal immune activation in neurodevelopmental disorders. Developmental Dynamics . 2018;247(4):588– 619. doi: 10.1002/dvdy.24612</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Smigielski L, Jagannath V, Rössler W, Walitza S, Grünblatt E. Epigenetic mechanisms in schizophrenia and other psychotic disorders: a systematic review of empirical human findings. Mol Psychiatry . 2020;25(8):1718–1748. doi: 10.1038/s41380-019-0601-3</mixed-citation><mixed-citation xml:lang="en">Smigielski L, Jagannath V, Rössler W, Walitza S, Grünblatt E. Epigenetic mechanisms in schizophrenia and other psychotic disorders: a systematic review of empirical human findings. Mol Psychiatry . 2020;25(8):1718–1748. doi: 10.1038/s41380-019-0601-3</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Lanz TA, Reinhart V, Sheehan MJ, Rizzo SJS, Bove SE, James LC, Volfson D, Lewis DA, Kleiman RJ. Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cor-tex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disor-der. Transl Psychiatr y . 2019;9(1):151. doi: 10.1038/s41398-019-0492-8</mixed-citation><mixed-citation xml:lang="en">Lanz TA, Reinhart V, Sheehan MJ, Rizzo SJS, Bove SE, James LC, Volfson D, Lewis DA, Kleiman RJ. Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cor-tex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disor-der. Transl Psychiatr y . 2019;9(1):151. doi: 10.1038/s41398-019-0492-8</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Momtazmanesh S, Zare-Shahabadi A, Rezaei N. Cy-tokine Alterations in Schizophrenia: An Updated Review. Front Psychiatry. 2019;10:892. doi: 10.3389/fpsyt.2019.00892</mixed-citation><mixed-citation xml:lang="en">Momtazmanesh S, Zare-Shahabadi A, Rezaei N. Cy-tokine Alterations in Schizophrenia: An Updated Review. Front Psychiatry. 2019;10:892. doi: 10.3389/fpsyt.2019.00892</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Müller N. Immunological aspects of the treatment of depression and schizophrenia. Dialogues Clin Neuros-ci . 2017;19(1):55–63. doi: 10.31887/DCNS.2017.19.1/nmueller</mixed-citation><mixed-citation xml:lang="en">Müller N. Immunological aspects of the treatment of depression and schizophrenia. Dialogues Clin Neuros-ci . 2017;19(1):55–63. doi: 10.31887/DCNS.2017.19.1/nmueller</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Z, Li X, Zhou H, Zhou J. NG2-glia crosstalk with microglia in health and disease. CNS Neurosci Ther. 2022;28(11):1663–1674. doi: 10.1111/cns.13948</mixed-citation><mixed-citation xml:lang="en">Zhang Z, Li X, Zhou H, Zhou J. NG2-glia crosstalk with microglia in health and disease. CNS Neurosci Ther. 2022;28(11):1663–1674. doi: 10.1111/cns.13948</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Guo S, Wang H, Yin Y. Microglia Polarization From M1 to M2 in Neurodegenerative Diseases. Front Aging Neurosci. 2022;14:815347. doi: 10.3389/fnagi.2022.815347</mixed-citation><mixed-citation xml:lang="en">Guo S, Wang H, Yin Y. Microglia Polarization From M1 to M2 in Neurodegenerative Diseases. Front Aging Neurosci. 2022;14:815347. doi: 10.3389/fnagi.2022.815347</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Hughes EG, Kang SH, Fukaya M, Bergles DE. Oligodendrocyte progenitors balance growth with self-repulsion to achieve homeostasis in the adult brain. Nat Neurosci. 2013;16(6):668–676. doi: 10.1038/nn.3390</mixed-citation><mixed-citation xml:lang="en">Hughes EG, Kang SH, Fukaya M, Bergles DE. Oligodendrocyte progenitors balance growth with self-repulsion to achieve homeostasis in the adult brain. Nat Neurosci. 2013;16(6):668–676. doi: 10.1038/nn.3390</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Kuhn S, Gritti L, Crooks D, Dombrowski Y. Oligodendrocytes in Development, Myelin Generation and Beyond. Cells. 2019;8(11):1424. doi: 10.3390/cells8111424</mixed-citation><mixed-citation xml:lang="en">Kuhn S, Gritti L, Crooks D, Dombrowski Y. Oligodendrocytes in Development, Myelin Generation and Beyond. Cells. 2019;8(11):1424. doi: 10.3390/cells8111424</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang SZ, Wang QQ, Yang QQ, Gu HY, Yin YQ, Li YD, Hou JC, Chen R, Sun QQ, Sun YF, Hu G, Zhou JW. NG2 glia regulate brain innate immunity via TGF-β2/TG-FBR2 axis. BMC Med. 2019;17(1):204. doi: 10.1186/s12916-019-1439-x</mixed-citation><mixed-citation xml:lang="en">Zhang SZ, Wang QQ, Yang QQ, Gu HY, Yin YQ, Li YD, Hou JC, Chen R, Sun QQ, Sun YF, Hu G, Zhou JW. NG2 glia regulate brain innate immunity via TGF-β2/TG-FBR2 axis. BMC Med. 2019;17(1):204. doi: 10.1186/s12916-019-1439-x</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Seo JH, Maki T, Maeda M, Miyamoto N, Liang AC, Hayakawa K, Pham LD, Suwa F, Taguchi A, Matsuyama T, Ihara M, Kim KW, Lo EH, Arai K. Oligodendrocyte precursor cells support blood-brain barrier integrity via TGF-β signaling. PLoS One . 2014;9(7):e103174. doi: 10.1371/journal.pone.0103174</mixed-citation><mixed-citation xml:lang="en">Seo JH, Maki T, Maeda M, Miyamoto N, Liang AC, Hayakawa K, Pham LD, Suwa F, Taguchi A, Matsuyama T, Ihara M, Kim KW, Lo EH, Arai K. Oligodendrocyte precursor cells support blood-brain barrier integrity via TGF-β signaling. PLoS One . 2014;9(7):e103174. doi: 10.1371/journal.pone.0103174</mixed-citation></citation-alternatives></ref><ref id="cit78"><label>78</label><citation-alternatives><mixed-citation xml:lang="ru">Palazuelos J, Klingener M, Aguirre A. TGFβ signaling regulates the timing of CNS myelination by modulating oligodendrocyte progenitor cell cycle exit through SMAD3/4/FoxO1/Sp1. J Neurosci. 2014;34(23):7917–7930. doi: 10.1523/JNEUROS-CI.0363-14.2014</mixed-citation><mixed-citation xml:lang="en">Palazuelos J, Klingener M, Aguirre A. TGFβ signaling regulates the timing of CNS myelination by modulating oligodendrocyte progenitor cell cycle exit through SMAD3/4/FoxO1/Sp1. J Neurosci. 2014;34(23):7917–7930. doi: 10.1523/JNEUROS-CI.0363-14.2014</mixed-citation></citation-alternatives></ref><ref id="cit79"><label>79</label><citation-alternatives><mixed-citation xml:lang="ru">Vela JM, Molina-Holgado E, Arévalo-Martín A, Almazán G, Guaza C. Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells. Mol Cell Neurosci. 2002;20(3):489–502. doi: 10.1006/mcne.2002.1127</mixed-citation><mixed-citation xml:lang="en">Vela JM, Molina-Holgado E, Arévalo-Martín A, Almazán G, Guaza C. Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells. Mol Cell Neurosci. 2002;20(3):489–502. doi: 10.1006/mcne.2002.1127</mixed-citation></citation-alternatives></ref><ref id="cit80"><label>80</label><citation-alternatives><mixed-citation xml:lang="ru">Matejuk A, Vandenbark AA, Offner H. Cross-Talk of the CNS With Immune Cells and Functions in Health and Disease. Front Neurol. 2021;12:672455. doi: 10.3389/fneur.2021.672455 PMID: 34135852; PMCID: PMC8200536.</mixed-citation><mixed-citation xml:lang="en">Matejuk A, Vandenbark AA, Offner H. Cross-Talk of the CNS With Immune Cells and Functions in Health and Disease. Front Neurol. 2021;12:672455. doi: 10.3389/fneur.2021.672455 PMID: 34135852; PMCID: PMC8200536.</mixed-citation></citation-alternatives></ref><ref id="cit81"><label>81</label><citation-alternatives><mixed-citation xml:lang="ru">Seo JH, Miyamoto N, Hayakawa K, Pham LD, Maki T, Ayata C, Kim KW, Lo EH, Arai K. Oligodendrocyte precursors induce early blood-brain barrier opening after white matter injury. J Clin Invest . 2013;123(2):782– 786. doi: 10.1172/JCI65863</mixed-citation><mixed-citation xml:lang="en">Seo JH, Miyamoto N, Hayakawa K, Pham LD, Maki T, Ayata C, Kim KW, Lo EH, Arai K. Oligodendrocyte precursors induce early blood-brain barrier opening after white matter injury. J Clin Invest . 2013;123(2):782– 786. doi: 10.1172/JCI65863</mixed-citation></citation-alternatives></ref><ref id="cit82"><label>82</label><citation-alternatives><mixed-citation xml:lang="ru">Gadani SP, Walsh JT, Smirnov I, Zheng J, Kipnis J. The gliaderived alarmin IL-33 orchestrates the immune response and promotes recovery following CNS injury. Neuron. 2015;85(4):703–709. doi: 10.1016/j.neuron.2015.01.01</mixed-citation><mixed-citation xml:lang="en">Gadani SP, Walsh JT, Smirnov I, Zheng J, Kipnis J. The gliaderived alarmin IL-33 orchestrates the immune response and promotes recovery following CNS injury. Neuron. 2015;85(4):703–709. doi: 10.1016/j.neuron.2015.01.01</mixed-citation></citation-alternatives></ref><ref id="cit83"><label>83</label><citation-alternatives><mixed-citation xml:lang="ru">Laskaris LE, Di Biase MA, Everall I, Chana G, Christopoulos A, Skafidas E, Cropley VL, Pantelis C. Microglial activation and progressive brain changes in schizophrenia. Br J Pharmacol. 2016;173(4):666–680. doi: 10.1111/bph.13364</mixed-citation><mixed-citation xml:lang="en">Laskaris LE, Di Biase MA, Everall I, Chana G, Christopoulos A, Skafidas E, Cropley VL, Pantelis C. Microglial activation and progressive brain changes in schizophrenia. Br J Pharmacol. 2016;173(4):666–680. doi: 10.1111/bph.13364</mixed-citation></citation-alternatives></ref><ref id="cit84"><label>84</label><citation-alternatives><mixed-citation xml:lang="ru">Chu T, Zhang YP, Tian Z, Ye C, Zhu M, Shields LBE, Kong M, Barnes GN, Shields CB, Cai J. Dynamic response of microglia/macrophage polarization following demyelination in mice. J Neuroinflammation . 2019;16(1):188. doi: 10.1186/s12974-019-1586-1</mixed-citation><mixed-citation xml:lang="en">Chu T, Zhang YP, Tian Z, Ye C, Zhu M, Shields LBE, Kong M, Barnes GN, Shields CB, Cai J. Dynamic response of microglia/macrophage polarization following demyelination in mice. J Neuroinflammation . 2019;16(1):188. doi: 10.1186/s12974-019-1586-1</mixed-citation></citation-alternatives></ref><ref id="cit85"><label>85</label><citation-alternatives><mixed-citation xml:lang="ru">Li Y, Liu Z, Song Y, Pan JJ, Jiang Y, Shi X, Liu C, Ma Y, Luo L, Mamtilahun M, Shi Z, Khan H, Xie Q, Wang Y, Tang Y, Zhang Z, Yang GY. M2 microglia-derived extracellular vesicles promote white matter repair and functional recovery via miR-23a-5p after cerebral ischemia in mice. Theranostics. 2022;12(7):3553– 3573. doi: 10.7150/thno.68895</mixed-citation><mixed-citation xml:lang="en">Li Y, Liu Z, Song Y, Pan JJ, Jiang Y, Shi X, Liu C, Ma Y, Luo L, Mamtilahun M, Shi Z, Khan H, Xie Q, Wang Y, Tang Y, Zhang Z, Yang GY. M2 microglia-derived extracellular vesicles promote white matter repair and functional recovery via miR-23a-5p after cerebral ischemia in mice. Theranostics. 2022;12(7):3553– 3573. doi: 10.7150/thno.68895</mixed-citation></citation-alternatives></ref><ref id="cit86"><label>86</label><citation-alternatives><mixed-citation xml:lang="ru">Miron VE, Boyd A, Zhao JW, Yuen TJ, Ruckh JM, Shadrach JL, van Wijngaarden P, Wagers AJ, Williams A, Franklin RJM, Ffrench-Constant C. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat Neurosci . 2013;16(9):1211–1218. doi: 10.1038/nn.3469</mixed-citation><mixed-citation xml:lang="en">Miron VE, Boyd A, Zhao JW, Yuen TJ, Ruckh JM, Shadrach JL, van Wijngaarden P, Wagers AJ, Williams A, Franklin RJM, Ffrench-Constant C. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat Neurosci . 2013;16(9):1211–1218. doi: 10.1038/nn.3469</mixed-citation></citation-alternatives></ref><ref id="cit87"><label>87</label><citation-alternatives><mixed-citation xml:lang="ru">Kronenberg J, Pars K, Brieskorn M, Prajeeth CK, Heckers S, Schwenkenbecher P, Skripuletz T, Pul R, Pavlou A, Stangel M. Fumaric Acids Directly Influence Gene Expression of Neuroprotective Factors in Rodent Microglia. Int J Mol Sci. 2019;20(2):325. doi: 10.3390/ijms20020325</mixed-citation><mixed-citation xml:lang="en">Kronenberg J, Pars K, Brieskorn M, Prajeeth CK, Heckers S, Schwenkenbecher P, Skripuletz T, Pul R, Pavlou A, Stangel M. Fumaric Acids Directly Influence Gene Expression of Neuroprotective Factors in Rodent Microglia. Int J Mol Sci. 2019;20(2):325. doi: 10.3390/ijms20020325</mixed-citation></citation-alternatives></ref><ref id="cit88"><label>88</label><citation-alternatives><mixed-citation xml:lang="ru">Taylor DL, Pirianov G, Holland S, McGinnity CJ, Norman AL, Reali C, Diemel LT, Gveric D, Yeung D, Mehmet H. Attenuation of proliferation in oligodendrocyte precursor cells by activated microglia. J Neurosci Res. 2010;88(8):1632–1644. doi: 10.1002/jnr.22335</mixed-citation><mixed-citation xml:lang="en">Taylor DL, Pirianov G, Holland S, McGinnity CJ, Norman AL, Reali C, Diemel LT, Gveric D, Yeung D, Mehmet H. Attenuation of proliferation in oligodendrocyte precursor cells by activated microglia. J Neurosci Res. 2010;88(8):1632–1644. doi: 10.1002/jnr.22335</mixed-citation></citation-alternatives></ref><ref id="cit89"><label>89</label><citation-alternatives><mixed-citation xml:lang="ru">Plastini MJ, HL, Brambilla R. Dynamic Responses of Microglia in Animal Models of Multiple Sclerosis. Front Cell Neurosci . 2020;14:269. doi: 10.3389/fn-cel.2020.00269</mixed-citation><mixed-citation xml:lang="en">Plastini MJ, HL, Brambilla R. Dynamic Responses of Microglia in Animal Models of Multiple Sclerosis. Front Cell Neurosci . 2020;14:269. doi: 10.3389/fn-cel.2020.00269</mixed-citation></citation-alternatives></ref><ref id="cit90"><label>90</label><citation-alternatives><mixed-citation xml:lang="ru">Kirby L, Jin J, Cardona JG, Smith MD, Martin KA, Wang J, Strasburger H, Herbst L, Alexis M, Karnell J, Davidson T, Dutta R, Goverman J, Bergles D, Calabresi PA. Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination. Nat Commun. 2019;10(1):3887. doi: 10.1038/s41467-019-11638-3</mixed-citation><mixed-citation xml:lang="en">Kirby L, Jin J, Cardona JG, Smith MD, Martin KA, Wang J, Strasburger H, Herbst L, Alexis M, Karnell J, Davidson T, Dutta R, Goverman J, Bergles D, Calabresi PA. Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination. Nat Commun. 2019;10(1):3887. doi: 10.1038/s41467-019-11638-3</mixed-citation></citation-alternatives></ref><ref id="cit91"><label>91</label><citation-alternatives><mixed-citation xml:lang="ru">Goldsmith DR, Bekhbat M, Mehta ND, Felger JC. Inflammation-Related Functional and Structural Dysconnectivity as a Pathway to Psychopathology. Biol Psychiatry . 2023;93(5):405–418. doi: 10.1016/j.biopsych.2022.11.003 Epub 2022 Nov 9. PMID: 36725140; PMCID: PMC9895884.</mixed-citation><mixed-citation xml:lang="en">Goldsmith DR, Bekhbat M, Mehta ND, Felger JC. Inflammation-Related Functional and Structural Dysconnectivity as a Pathway to Psychopathology. Biol Psychiatry . 2023;93(5):405–418. doi: 10.1016/j.biopsych.2022.11.003 Epub 2022 Nov 9. PMID: 36725140; PMCID: PMC9895884.</mixed-citation></citation-alternatives></ref><ref id="cit92"><label>92</label><citation-alternatives><mixed-citation xml:lang="ru">Michalczyk A, Tyburski E, Podwalski P, Waszczuk K, Rudkowski K, Kucharska-Mazur J, Mak M, Rek-Owodziń K, Plichta P, Bielecki M, Andrusewicz W, Cecerska-Heryć E, Samochowiec A, Misiak B, Sagan L, Samochowiec J. Serum Inflammatory Markers and Their Associations with the Integrity of the Cingulum Bundle in Schizophrenia, from Prodromal Stages to Chronic Psychosis. J Clin Med. 2022;11(21):6352. doi: 10.3390/jcm11216352</mixed-citation><mixed-citation xml:lang="en">Michalczyk A, Tyburski E, Podwalski P, Waszczuk K, Rudkowski K, Kucharska-Mazur J, Mak M, Rek-Owodziń K, Plichta P, Bielecki M, Andrusewicz W, Cecerska-Heryć E, Samochowiec A, Misiak B, Sagan L, Samochowiec J. Serum Inflammatory Markers and Their Associations with the Integrity of the Cingulum Bundle in Schizophrenia, from Prodromal Stages to Chronic Psychosis. J Clin Med. 2022;11(21):6352. doi: 10.3390/jcm11216352</mixed-citation></citation-alternatives></ref><ref id="cit93"><label>93</label><citation-alternatives><mixed-citation xml:lang="ru">Waszczuk K, Rek-Owodziń K, Tyburski E, Mak M, Misiak B, Samochowiec J. Disturbances in White Matter Integrity in the Ultra-High-Risk Psychosis State — A Systematic Review. J Clin Med . 2021;10:2515. doi: 10.3390/jcm10112515</mixed-citation><mixed-citation xml:lang="en">Waszczuk K, Rek-Owodziń K, Tyburski E, Mak M, Misiak B, Samochowiec J. Disturbances in White Matter Integrity in the Ultra-High-Risk Psychosis State — A Systematic Review. J Clin Med . 2021;10:2515. doi: 10.3390/jcm10112515</mixed-citation></citation-alternatives></ref><ref id="cit94"><label>94</label><citation-alternatives><mixed-citation xml:lang="ru">Howes D, McCutcheon R. Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization. Transl Psychiatr y. 2017;7(2):e1024. doi: 10.1038/tp.2016.278</mixed-citation><mixed-citation xml:lang="en">Howes D, McCutcheon R. Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization. Transl Psychiatr y. 2017;7(2):e1024. doi: 10.1038/tp.2016.278</mixed-citation></citation-alternatives></ref><ref id="cit95"><label>95</label><citation-alternatives><mixed-citation xml:lang="ru">Deczkowska A, Keren-Shaul H, Weiner A, Colonna M, Schwartz M, Amit I. Disease-Associated Microglia: A Universal Immune Sensor of Neurodegeneration. Cell. 2018;173(5):1073–1081. doi: 10.1016/j.cell.2018.05.003</mixed-citation><mixed-citation xml:lang="en">Deczkowska A, Keren-Shaul H, Weiner A, Colonna M, Schwartz M, Amit I. Disease-Associated Microglia: A Universal Immune Sensor of Neurodegeneration. Cell. 2018;173(5):1073–1081. doi: 10.1016/j.cell.2018.05.003</mixed-citation></citation-alternatives></ref><ref id="cit96"><label>96</label><citation-alternatives><mixed-citation xml:lang="ru">Gober R, Ardalan M, Shiadeh SMJ, Duque L, Garamszegi SP, Ascona M, Barreda A, Sun X, Mallard C, Vontell RT. Microglia activation in postmortem brains with schizophrenia demonstrates distinct morphological changes between brain regions. Brain Pathol . 2022;32(1):e13003. doi: 10.1111/bpa.13003</mixed-citation><mixed-citation xml:lang="en">Gober R, Ardalan M, Shiadeh SMJ, Duque L, Garamszegi SP, Ascona M, Barreda A, Sun X, Mallard C, Vontell RT. Microglia activation in postmortem brains with schizophrenia demonstrates distinct morphological changes between brain regions. Brain Pathol . 2022;32(1):e13003. doi: 10.1111/bpa.13003</mixed-citation></citation-alternatives></ref><ref id="cit97"><label>97</label><citation-alternatives><mixed-citation xml:lang="ru">Uranova NA, Vikhreva OV, Rakhmanova VI. Abnormal microglial reactivity in gray matter of the prefrontal cortex in schizophrenia. Asian J Psychiatr. 2021;3:102752. doi: 10.1016/j.ajp.2021.102752</mixed-citation><mixed-citation xml:lang="en">Uranova NA, Vikhreva OV, Rakhmanova VI. Abnormal microglial reactivity in gray matter of the prefrontal cortex in schizophrenia. Asian J Psychiatr. 2021;3:102752. doi: 10.1016/j.ajp.2021.102752</mixed-citation></citation-alternatives></ref><ref id="cit98"><label>98</label><citation-alternatives><mixed-citation xml:lang="ru">St-Pierre MK, Šimončičová E, Bögi E, Tremblay MÈ. Shedding Light on the Dark Side of the Microglia. ASN Neuro . 2020;12:1759091420925335. doi: 10.1177/1759091420925335</mixed-citation><mixed-citation xml:lang="en">St-Pierre MK, Šimončičová E, Bögi E, Tremblay MÈ. Shedding Light on the Dark Side of the Microglia. ASN Neuro . 2020;12:1759091420925335. doi: 10.1177/1759091420925335</mixed-citation></citation-alternatives></ref><ref id="cit99"><label>99</label><citation-alternatives><mixed-citation xml:lang="ru">Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, Jones T, Banati RB. In-vivo measurement of activated microglia in dementia. Lancet. 2001;358(9280):461–467. doi: 10.1016/S0140-6736(01)05625-2</mixed-citation><mixed-citation xml:lang="en">Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, Jones T, Banati RB. In-vivo measurement of activated microglia in dementia. Lancet. 2001;358(9280):461–467. doi: 10.1016/S0140-6736(01)05625-2</mixed-citation></citation-alternatives></ref><ref id="cit100"><label>100</label><citation-alternatives><mixed-citation xml:lang="ru">Pasternak O, Kubicki M, Shenton ME. In vivo imaging of neuroinflammation in schizophrenia. Schizophr Res. 2016;173(3):200–212. doi: 10.1016/j.schres.2015.05.034 Epub 2015 Jun 3. PMID: 26048294; PMCID: PMC4668243.</mixed-citation><mixed-citation xml:lang="en">Pasternak O, Kubicki M, Shenton ME. In vivo imaging of neuroinflammation in schizophrenia. Schizophr Res. 2016;173(3):200–212. doi: 10.1016/j.schres.2015.05.034 Epub 2015 Jun 3. PMID: 26048294; PMCID: PMC4668243.</mixed-citation></citation-alternatives></ref><ref id="cit101"><label>101</label><citation-alternatives><mixed-citation xml:lang="ru">Bishop JR, Zhang L, Lizano P. Inflammation Subtypes and Translating Inflammation-Related Genetic Findings in Schizophrenia and Related Psychoses: A Perspective on Pathways for Treatment Stratifation and Novel Therapies. Harv Rev Psychiatry . 2022;30(1):59– 70. doi: 10.1097/HRP.0000000000000321</mixed-citation><mixed-citation xml:lang="en">Bishop JR, Zhang L, Lizano P. Inflammation Subtypes and Translating Inflammation-Related Genetic Findings in Schizophrenia and Related Psychoses: A Perspective on Pathways for Treatment Stratifation and Novel Therapies. Harv Rev Psychiatry . 2022;30(1):59– 70. doi: 10.1097/HRP.0000000000000321</mixed-citation></citation-alternatives></ref><ref id="cit102"><label>102</label><citation-alternatives><mixed-citation xml:lang="ru">Stamoula Ε, Ainatzoglou A, Stamatellos VP, Dardalas I, Siafis S, Matsas A, Stamoulas K, Papazisis G. Atypical antipsychotics in multiple sclerosis: A review of their in vivo immunomodulatory effects. Mult Scler Relat Disord. 2022;58:103522. doi: 10.1016/j.msard.2022.103522</mixed-citation><mixed-citation xml:lang="en">Stamoula Ε, Ainatzoglou A, Stamatellos VP, Dardalas I, Siafis S, Matsas A, Stamoulas K, Papazisis G. Atypical antipsychotics in multiple sclerosis: A review of their in vivo immunomodulatory effects. Mult Scler Relat Disord. 2022;58:103522. doi: 10.1016/j.msard.2022.103522</mixed-citation></citation-alternatives></ref><ref id="cit103"><label>103</label><citation-alternatives><mixed-citation xml:lang="ru">Ceylan U, Haupeltshofer S, Kämper L, Dann J, Ambrosius B, Gold R, Faissner S. Clozapine Regulates Microglia and Is Effective in Chronic Experimental Autoimmune Encephalomyelitis. Front Immunol. 2021;12:656941. doi: 10.3389/fimmu.2021.656941</mixed-citation><mixed-citation xml:lang="en">Ceylan U, Haupeltshofer S, Kämper L, Dann J, Ambrosius B, Gold R, Faissner S. Clozapine Regulates Microglia and Is Effective in Chronic Experimental Autoimmune Encephalomyelitis. Front Immunol. 2021;12:656941. doi: 10.3389/fimmu.2021.656941</mixed-citation></citation-alternatives></ref><ref id="cit104"><label>104</label><citation-alternatives><mixed-citation xml:lang="ru">O’Sullivan D, Green L, Stone S, Zareie P, Kharkrang M, Fong D, Connor B, La Flamme AC. Treatment with the antipsychotic agent, risperidone, reduces disease severity in experimental autoimmune encephalomy-elitis. PLoS One . 2014;9(8):e104430. doi: 10.1371/journal.pone.0104430</mixed-citation><mixed-citation xml:lang="en">O’Sullivan D, Green L, Stone S, Zareie P, Kharkrang M, Fong D, Connor B, La Flamme AC. Treatment with the antipsychotic agent, risperidone, reduces disease severity in experimental autoimmune encephalomy-elitis. PLoS One . 2014;9(8):e104430. doi: 10.1371/journal.pone.0104430</mixed-citation></citation-alternatives></ref><ref id="cit105"><label>105</label><citation-alternatives><mixed-citation xml:lang="ru">Zhornitsky S, Yong V W, Koch MW, Mackie A, Potvin S, Patten SB, Metz LM. Quetiapine Fumarate for the Treatment of Multiple Sclerosis: Focus on Myelin Repair. CNS Neurosci Ther . 2013;19(10):737–744. doi: 10.1111/cns.12154</mixed-citation><mixed-citation xml:lang="en">Zhornitsky S, Yong V W, Koch MW, Mackie A, Potvin S, Patten SB, Metz LM. Quetiapine Fumarate for the Treatment of Multiple Sclerosis: Focus on Myelin Repair. CNS Neurosci Ther . 2013;19(10):737–744. doi: 10.1111/cns.12154</mixed-citation></citation-alternatives></ref><ref id="cit106"><label>106</label><citation-alternatives><mixed-citation xml:lang="ru">Xiao L, Xu H, Zhang Y, Wei Z, He J, Jiang W, Li X, Dyck LE, Devon RM, Deng Y, Li XM. Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes. Mol Psychiatry. 2008;13(7):697–708. doi: 10.1038/sj.mp.4002064</mixed-citation><mixed-citation xml:lang="en">Xiao L, Xu H, Zhang Y, Wei Z, He J, Jiang W, Li X, Dyck LE, Devon RM, Deng Y, Li XM. Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes. Mol Psychiatry. 2008;13(7):697–708. doi: 10.1038/sj.mp.4002064</mixed-citation></citation-alternatives></ref><ref id="cit107"><label>107</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Y, Zhang H, Wang L, Jiang W, Xu H, Xiao L, Bi X, Wang J, Zhu S, Zhang R, He J, Tan Q, Zhang D, Kong J, Li XM. Quetiapine enhances oligodendrocyte regeneration and myelin repair after cuprizone-induced demyelination. Schizophr Res . 2012;138(1):8–17. doi: 10.1016/j.schres.2012.04.006</mixed-citation><mixed-citation xml:lang="en">Zhang Y, Zhang H, Wang L, Jiang W, Xu H, Xiao L, Bi X, Wang J, Zhu S, Zhang R, He J, Tan Q, Zhang D, Kong J, Li XM. Quetiapine enhances oligodendrocyte regeneration and myelin repair after cuprizone-induced demyelination. Schizophr Res . 2012;138(1):8–17. doi: 10.1016/j.schres.2012.04.006</mixed-citation></citation-alternatives></ref><ref id="cit108"><label>108</label><citation-alternatives><mixed-citation xml:lang="ru">Bi X, Zhang Y, Yan B, Fang S, He J, Zhang D, Zhang Z, Kong J, Tan Q, Li XM. Quetiapine prevents oligodendrocyte and myelin loss and promotes maturation of oligodendrocyte progenitors in the hippocampus of global cerebral ischemia mice. J Neurochem. 2012;123(1):14–20. doi: 10.1111/j.1471-4159.2012.07883.x</mixed-citation><mixed-citation xml:lang="en">Bi X, Zhang Y, Yan B, Fang S, He J, Zhang D, Zhang Z, Kong J, Tan Q, Li XM. Quetiapine prevents oligodendrocyte and myelin loss and promotes maturation of oligodendrocyte progenitors in the hippocampus of global cerebral ischemia mice. J Neurochem. 2012;123(1):14–20. doi: 10.1111/j.1471-4159.2012.07883.x</mixed-citation></citation-alternatives></ref><ref id="cit109"><label>109</label><citation-alternatives><mixed-citation xml:lang="ru">Mei F, Guo S, He Y, Wang L, Wang H, Niu J, Kong J, Li X, Wu Y, Xiao L. Quetiapine, an atypical antipsychotic, is protective against autoimmune-mediated demyelination by inhibiting effector T cell proliferation. PLoS One . 2012;7(8):e42746. doi: 10.1371/journal.pone.0042746</mixed-citation><mixed-citation xml:lang="en">Mei F, Guo S, He Y, Wang L, Wang H, Niu J, Kong J, Li X, Wu Y, Xiao L. Quetiapine, an atypical antipsychotic, is protective against autoimmune-mediated demyelination by inhibiting effector T cell proliferation. PLoS One . 2012;7(8):e42746. doi: 10.1371/journal.pone.0042746</mixed-citation></citation-alternatives></ref><ref id="cit110"><label>110</label><citation-alternatives><mixed-citation xml:lang="ru">Shao Y, Peng H, Huang Q, Kong J, Xu H. Quetiapine mitigates the neuroinflammation and oligodendrocyte loss in the brain of C57BL/6 mouse following cuprizone exposure for one week. Eur J Pharmacol . 2015;765:249–257. doi: 10.1016/j.ejphar.2015.08.046</mixed-citation><mixed-citation xml:lang="en">Shao Y, Peng H, Huang Q, Kong J, Xu H. Quetiapine mitigates the neuroinflammation and oligodendrocyte loss in the brain of C57BL/6 mouse following cuprizone exposure for one week. Eur J Pharmacol . 2015;765:249–257. doi: 10.1016/j.ejphar.2015.08.046</mixed-citation></citation-alternatives></ref><ref id="cit111"><label>111</label><citation-alternatives><mixed-citation xml:lang="ru">Wang H, Liu S, Tian Y, Wu X, He Y, Li C, Namaka M, Kong J, Li H, Xiao L. Quetiapine Inhibits Microglial Activation by Neutralizing Abnormal STIM1-Mediated Intercellular Calcium Homeostasis and Promotes Myelin Repair in a Cuprizone-Induced Mouse Model of Demyelination. Front Cell Neurosci . 2015;9:492. doi: 10.3389/fncel.2015.0049</mixed-citation><mixed-citation xml:lang="en">Wang H, Liu S, Tian Y, Wu X, He Y, Li C, Namaka M, Kong J, Li H, Xiao L. Quetiapine Inhibits Microglial Activation by Neutralizing Abnormal STIM1-Mediated Intercellular Calcium Homeostasis and Promotes Myelin Repair in a Cuprizone-Induced Mouse Model of Demyelination. Front Cell Neurosci . 2015;9:492. doi: 10.3389/fncel.2015.0049</mixed-citation></citation-alternatives></ref><ref id="cit112"><label>112</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu S, Shi R, Li V, Wang J, Zhang R, Tempier A, He J, Kong J, Wang JF, Li XM. Quetiapine attenuates glial activation and proinflammatory cytokines in APP/PS1 transgenic mice via inhibition of nuclear factor-κB pathway. Int J Neuropsychopharmacol. 2014;18(3):pyu022. doi: 10.1093/ijnp/pyu022 PMID: 25618401; PMCID: PMC4360237.</mixed-citation><mixed-citation xml:lang="en">Zhu S, Shi R, Li V, Wang J, Zhang R, Tempier A, He J, Kong J, Wang JF, Li XM. Quetiapine attenuates glial activation and proinflammatory cytokines in APP/PS1 transgenic mice via inhibition of nuclear factor-κB pathway. Int J Neuropsychopharmacol. 2014;18(3):pyu022. doi: 10.1093/ijnp/pyu022 PMID: 25618401; PMCID: PMC4360237.</mixed-citation></citation-alternatives></ref><ref id="cit113"><label>113</label><citation-alternatives><mixed-citation xml:lang="ru">Bian Q, Kato T, Monji A, Hashioka S, Mizoguchi Y, Horikawa H, Kanba S. The effect of atypical antipsychotics, perospirone, ziprasidone and quetiapine on microglial activation induced by interferon-gamma. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(1):42–58. doi: 10.1016/j.pnpbp.2007.06.031</mixed-citation><mixed-citation xml:lang="en">Bian Q, Kato T, Monji A, Hashioka S, Mizoguchi Y, Horikawa H, Kanba S. The effect of atypical antipsychotics, perospirone, ziprasidone and quetiapine on microglial activation induced by interferon-gamma. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(1):42–58. doi: 10.1016/j.pnpbp.2007.06.031</mixed-citation></citation-alternatives></ref><ref id="cit114"><label>114</label><citation-alternatives><mixed-citation xml:lang="ru">Himmerich H, Schönherr J, Fulda S, Sheldrick AJ, Bauer K , S ack U. Imp ac t of ant ip s ychot ic s on c y t ok ine production in vitro. J Psychiatr Res . 2011;45(10):1358– 1365. doi: 10.1016/j.jpsychires.2011.04.009</mixed-citation><mixed-citation xml:lang="en">Himmerich H, Schönherr J, Fulda S, Sheldrick AJ, Bauer K , S ack U. Imp ac t of ant ip s ychot ic s on c y t ok ine production in vitro. J Psychiatr Res . 2011;45(10):1358– 1365. doi: 10.1016/j.jpsychires.2011.04.009</mixed-citation></citation-alternatives></ref><ref id="cit115"><label>115</label><citation-alternatives><mixed-citation xml:lang="ru">Xu H, Yang HJ, McConomy B, Browning R, Li XM. Behavioral and neurobiological changes in C57BL/6 mouse exposed to cuprizone: effects of antipsychotics. Front Behav Neurosci. 2010;4:8. doi: 10.3389/fn-beh.2010.00008</mixed-citation><mixed-citation xml:lang="en">Xu H, Yang HJ, McConomy B, Browning R, Li XM. Behavioral and neurobiological changes in C57BL/6 mouse exposed to cuprizone: effects of antipsychotics. Front Behav Neurosci. 2010;4:8. doi: 10.3389/fn-beh.2010.00008</mixed-citation></citation-alternatives></ref><ref id="cit116"><label>116</label><citation-alternatives><mixed-citation xml:lang="ru">Matsushima GK, Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol . 2001;11(1):107–116. doi: 10.1111/j.1750-3639.2001.tb00385.x</mixed-citation><mixed-citation xml:lang="en">Matsushima GK, Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol . 2001;11(1):107–116. doi: 10.1111/j.1750-3639.2001.tb00385.x</mixed-citation></citation-alternatives></ref><ref id="cit117"><label>117</label><citation-alternatives><mixed-citation xml:lang="ru">Templeton N, Kivell B, McCaughey-Chapman A, Connor B, La Flamme AC. Clozapine administration enhanced functional recovery after cuprizone demyelination. PLoS One. 2019;14(5):e0216113. doi: 10.1371/journal.pone.0216113 PMID: 31071102; PMCID: PMC6508663.</mixed-citation><mixed-citation xml:lang="en">Templeton N, Kivell B, McCaughey-Chapman A, Connor B, La Flamme AC. Clozapine administration enhanced functional recovery after cuprizone demyelination. PLoS One. 2019;14(5):e0216113. doi: 10.1371/journal.pone.0216113 PMID: 31071102; PMCID: PMC6508663.</mixed-citation></citation-alternatives></ref><ref id="cit118"><label>118</label><citation-alternatives><mixed-citation xml:lang="ru">Madsen PM, Desu HL, de Rivero Vaccari JP, Florimon Y, Ellman DG, Keane RW, Clausen BH, Lambertsen KL, Brambilla R. Oligodendrocytes modulate the immune-inflammatory response in EAE via TNFR2 signaling. Brain Behav Immun. 2020;84:132–146. doi: 10.1016/j.bbi.2019.11.017</mixed-citation><mixed-citation xml:lang="en">Madsen PM, Desu HL, de Rivero Vaccari JP, Florimon Y, Ellman DG, Keane RW, Clausen BH, Lambertsen KL, Brambilla R. Oligodendrocytes modulate the immune-inflammatory response in EAE via TNFR2 signaling. Brain Behav Immun. 2020;84:132–146. doi: 10.1016/j.bbi.2019.11.017</mixed-citation></citation-alternatives></ref><ref id="cit119"><label>119</label><citation-alternatives><mixed-citation xml:lang="ru">Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, Ting JP. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci. 2001;4(11):1116–1122. doi: 10.1038/nn738 PMID: 11600888.</mixed-citation><mixed-citation xml:lang="en">Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, Ting JP. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci. 2001;4(11):1116–1122. doi: 10.1038/nn738 PMID: 11600888.</mixed-citation></citation-alternatives></ref><ref id="cit120"><label>120</label><citation-alternatives><mixed-citation xml:lang="ru">Robichon K, Patel V, Connor B, La Flamme AC. Clozapine reduces inflltration into the CNS by targeting migration in experimental autoimmune encephalomyelitis. J Neuroinflammation . 2020;17(1):53. doi: 10.1186/s12974-020-01733-4</mixed-citation><mixed-citation xml:lang="en">Robichon K, Patel V, Connor B, La Flamme AC. Clozapine reduces inflltration into the CNS by targeting migration in experimental autoimmune encephalomyelitis. J Neuroinflammation . 2020;17(1):53. doi: 10.1186/s12974-020-01733-4</mixed-citation></citation-alternatives></ref><ref id="cit121"><label>121</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu F, Zheng Y, Ding YQ, Liu Y, Zhang X, Wu R, Guo X, Zhao J. Minocycline and risperidone prevent microglia activation and rescue behavioral deficits induced by neonatal intrahippocampal injection of lipopoly-saccharide in rats. PLoS One . 2014;9(4):e93966. doi: 10.1371/journal.pone.0093966</mixed-citation><mixed-citation xml:lang="en">Zhu F, Zheng Y, Ding YQ, Liu Y, Zhang X, Wu R, Guo X, Zhao J. Minocycline and risperidone prevent microglia activation and rescue behavioral deficits induced by neonatal intrahippocampal injection of lipopoly-saccharide in rats. PLoS One . 2014;9(4):e93966. doi: 10.1371/journal.pone.0093966</mixed-citation></citation-alternatives></ref><ref id="cit122"><label>122</label><citation-alternatives><mixed-citation xml:lang="ru">Racki V, Marcelic M, Stimac I, Petric D, Kucic N. Effects of Haloperidol, Risperidone, and Aripiprazole on the Immunometabolic Properties of BV-2 Microglial Cells. Int J Mol Sci. 2021;22(9):4399. doi: 10.3390/ijms22094399</mixed-citation><mixed-citation xml:lang="en">Racki V, Marcelic M, Stimac I, Petric D, Kucic N. Effects of Haloperidol, Risperidone, and Aripiprazole on the Immunometabolic Properties of BV-2 Microglial Cells. Int J Mol Sci. 2021;22(9):4399. doi: 10.3390/ijms22094399</mixed-citation></citation-alternatives></ref><ref id="cit123"><label>123</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang H, Zhang Y, Xu H, Wang L, Adilijiang A, Wang J, Hartle K, Zhang Z, Zhang D, Tan Q, Kong J, Huang Q, Li XM. Olanzapine ameliorates neuropathological changes and increases IGF-1 expression in frontal cortex of C57BL/6 mice exposed to cuprizone. Psychiatry Res . 2014;216(3):438–445. doi: 10.1016/j.psychres.2014.02.019</mixed-citation><mixed-citation xml:lang="en">Zhang H, Zhang Y, Xu H, Wang L, Adilijiang A, Wang J, Hartle K, Zhang Z, Zhang D, Tan Q, Kong J, Huang Q, Li XM. Olanzapine ameliorates neuropathological changes and increases IGF-1 expression in frontal cortex of C57BL/6 mice exposed to cuprizone. Psychiatry Res . 2014;216(3):438–445. doi: 10.1016/j.psychres.2014.02.019</mixed-citation></citation-alternatives></ref><ref id="cit124"><label>124</label><citation-alternatives><mixed-citation xml:lang="ru">Kimoto S, Okuda A, Toritsuka M, Yamauchi T, Makinodan M, Okuda H, Tatsumi K, Nakamura Y, Wanaka A, Kishimoto T. Olanzapine stimulates proliferation but inhibits differentiation in rat oligodendrocyte precursor cell cultures. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(8):1950–1956. doi: 10.1016/j.pnpbp.2011.07.011</mixed-citation><mixed-citation xml:lang="en">Kimoto S, Okuda A, Toritsuka M, Yamauchi T, Makinodan M, Okuda H, Tatsumi K, Nakamura Y, Wanaka A, Kishimoto T. Olanzapine stimulates proliferation but inhibits differentiation in rat oligodendrocyte precursor cell cultures. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(8):1950–1956. doi: 10.1016/j.pnpbp.2011.07.011</mixed-citation></citation-alternatives></ref><ref id="cit125"><label>125</label><citation-alternatives><mixed-citation xml:lang="ru">Fang F, Zhang H, Zhang Y, Xu H, Huang Q, Adilijiang A, Wang J, Zhang Z, Zhang D, Tan Q, He J, Kong L, Liu Y, Li XM. Antipsychotics promote the differentiation of oligodendrocyte progenitor cells by regulating oligodendrocyte lineage transcription factors 1 and 2. Life Sci . 2013;93(12–14):429–434. doi: 10.1016/j.lfs.2013.08.004</mixed-citation><mixed-citation xml:lang="en">Fang F, Zhang H, Zhang Y, Xu H, Huang Q, Adilijiang A, Wang J, Zhang Z, Zhang D, Tan Q, He J, Kong L, Liu Y, Li XM. Antipsychotics promote the differentiation of oligodendrocyte progenitor cells by regulating oligodendrocyte lineage transcription factors 1 and 2. Life Sci . 2013;93(12–14):429–434. doi: 10.1016/j.lfs.2013.08.004</mixed-citation></citation-alternatives></ref><ref id="cit126"><label>126</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang H, Zhang Y, Xu H, Wang L, Adilijiang A, Wang J, Hartle K, Zhang Z, Zhang D, Tan Q, Kong J, Huang Q, Li XM. Olanzapine ameliorates neuropathological changes and increases IGF-1 expression in frontal cortex of C57BL/6 mice exposed to cuprizone. Psychiatry Res. 2014;216(3):438–445. doi: 10.1016/j.psychres.2014.02.019</mixed-citation><mixed-citation xml:lang="en">Zhang H, Zhang Y, Xu H, Wang L, Adilijiang A, Wang J, Hartle K, Zhang Z, Zhang D, Tan Q, Kong J, Huang Q, Li XM. Olanzapine ameliorates neuropathological changes and increases IGF-1 expression in frontal cortex of C57BL/6 mice exposed to cuprizone. Psychiatry Res. 2014;216(3):438–445. doi: 10.1016/j.psychres.2014.02.019</mixed-citation></citation-alternatives></ref><ref id="cit127"><label>127</label><citation-alternatives><mixed-citation xml:lang="ru">Ersland KM, Skrede S, Stansberg C, Steen VM. Subchronic olanzapine exposure leads to increased expression of myelination-related genes in rat fron-to-medial cortex. Transl Psychiatr y . 2017;7(11):1262. doi: 10.1038/s41398-017-0008-3</mixed-citation><mixed-citation xml:lang="en">Ersland KM, Skrede S, Stansberg C, Steen VM. Subchronic olanzapine exposure leads to increased expression of myelination-related genes in rat fron-to-medial cortex. Transl Psychiatr y . 2017;7(11):1262. doi: 10.1038/s41398-017-0008-3</mixed-citation></citation-alternatives></ref><ref id="cit128"><label>128</label><citation-alternatives><mixed-citation xml:lang="ru">Burghardt KJ, Khoury AS, Msallaty Z, Yi Z, Seyoum B. Antipsychotic Medications and DNA Methylation in Schizophrenia and Bipolar Disorder: A Systematic Review. Pharmacotherapy. 2020;40(4):331–342. doi: 10.1002/phar.2375</mixed-citation><mixed-citation xml:lang="en">Burghardt KJ, Khoury AS, Msallaty Z, Yi Z, Seyoum B. Antipsychotic Medications and DNA Methylation in Schizophrenia and Bipolar Disorder: A Systematic Review. Pharmacotherapy. 2020;40(4):331–342. doi: 10.1002/phar.2375</mixed-citation></citation-alternatives></ref><ref id="cit129"><label>129</label><citation-alternatives><mixed-citation xml:lang="ru">Leroux E, Vandevelde A, Tréhout M, Dollfus S. Abnormalities of fronto-subcortical pathways in schizophrenia and the differential impacts of antipsychotic treatment: a DTI-based tractography study. Psychiatry Res Neuroimaging. 2018;280:22–29. doi: 10.1016/j.pscychresns.2018.08.008</mixed-citation><mixed-citation xml:lang="en">Leroux E, Vandevelde A, Tréhout M, Dollfus S. Abnormalities of fronto-subcortical pathways in schizophrenia and the differential impacts of antipsychotic treatment: a DTI-based tractography study. Psychiatry Res Neuroimaging. 2018;280:22–29. doi: 10.1016/j.pscychresns.2018.08.008</mixed-citation></citation-alternatives></ref><ref id="cit130"><label>130</label><citation-alternatives><mixed-citation xml:lang="ru">Luo C, Lencer R, Hu N, Xiao Y, Zhang W, Li S, Lui S, Gong Q. Characteristics of White Matter Structural Networks in Chronic Schizophrenia Treated with Clozapine or Risperidone and Those Never Treated. Int J Neuropsychopharmacol . 2020;23(12):799–810. doi: 10.1093/ijnp/pyaa061</mixed-citation><mixed-citation xml:lang="en">Luo C, Lencer R, Hu N, Xiao Y, Zhang W, Li S, Lui S, Gong Q. Characteristics of White Matter Structural Networks in Chronic Schizophrenia Treated with Clozapine or Risperidone and Those Never Treated. Int J Neuropsychopharmacol . 2020;23(12):799–810. doi: 10.1093/ijnp/pyaa061</mixed-citation></citation-alternatives></ref><ref id="cit131"><label>131</label><citation-alternatives><mixed-citation xml:lang="ru">Hu ML, Zong XF, Zheng JJ, Pantazatos SP, Miller JM, Li ZC, Liao YH, He Y, Zhou J, Sang DE, Zhao HZ, Lv LX, Tang JS, Mann JJ, Chen XG. Short-term Effects of Risperidone Monotherapy on Spontaneous Brain Activ ity in First-episode Treatment-naïve Schizophrenia Patients: A Longitudinal fMRI Study. Sci Rep. 2016;6:34287. doi: 10.1038/srep34287</mixed-citation><mixed-citation xml:lang="en">Hu ML, Zong XF, Zheng JJ, Pantazatos SP, Miller JM, Li ZC, Liao YH, He Y, Zhou J, Sang DE, Zhao HZ, Lv LX, Tang JS, Mann JJ, Chen XG. Short-term Effects of Risperidone Monotherapy on Spontaneous Brain Activ ity in First-episode Treatment-naïve Schizophrenia Patients: A Longitudinal fMRI Study. Sci Rep. 2016;6:34287. doi: 10.1038/srep34287</mixed-citation></citation-alternatives></ref><ref id="cit132"><label>132</label><citation-alternatives><mixed-citation xml:lang="ru">Wu R, Ou Y, Liu F, Chen J, Li H, Zhao J, Guo W, Fan X. Reduced Brain Activity in the Right Putamen as an Early Predictor for Treatment Response in Drug-Naive, First-Episode Schizophrenia. Front Psychiatry . 2019;10:741. doi: 10.3389/fpsyt.2019.00741</mixed-citation><mixed-citation xml:lang="en">Wu R, Ou Y, Liu F, Chen J, Li H, Zhao J, Guo W, Fan X. Reduced Brain Activity in the Right Putamen as an Early Predictor for Treatment Response in Drug-Naive, First-Episode Schizophrenia. Front Psychiatry . 2019;10:741. doi: 10.3389/fpsyt.2019.00741</mixed-citation></citation-alternatives></ref><ref id="cit133"><label>133</label><citation-alternatives><mixed-citation xml:lang="ru">Aringhieri S, Carli M, Kolachalam S, Verdesca V, Cini E, Rossi M, McCormick PJ, Corsini GU, Maggio R, Scarselli M. Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences. Pharmacol Ther. 2018;192:20–41. doi: 10.1016/j.pharmthera.2018.06.012</mixed-citation><mixed-citation xml:lang="en">Aringhieri S, Carli M, Kolachalam S, Verdesca V, Cini E, Rossi M, McCormick PJ, Corsini GU, Maggio R, Scarselli M. Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences. Pharmacol Ther. 2018;192:20–41. doi: 10.1016/j.pharmthera.2018.06.012</mixed-citation></citation-alternatives></ref><ref id="cit134"><label>134</label><citation-alternatives><mixed-citation xml:lang="ru">Arnt J, Skarsfeldt T. Do novel ant ipsychot ics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology. 1998;18(2):63– 101. doi: 10.1016/S0893-133X(97)00112-7</mixed-citation><mixed-citation xml:lang="en">Arnt J, Skarsfeldt T. Do novel ant ipsychot ics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology. 1998;18(2):63– 101. doi: 10.1016/S0893-133X(97)00112-7</mixed-citation></citation-alternatives></ref><ref id="cit135"><label>135</label><citation-alternatives><mixed-citation xml:lang="ru">Bymaster FP, Felder CC, Tzavara E, Nomikos GG, Calligaro DO, Mckinzie DL. Muscarinic mechanisms of antipsychotic atypicality. Prog Neuropsycho-pharmacol Biol Psychiatry . 2003;27(7):1125–1143. doi: 10.1016/j.pnpbp.2003.09.008 PMID: 14642972</mixed-citation><mixed-citation xml:lang="en">Bymaster FP, Felder CC, Tzavara E, Nomikos GG, Calligaro DO, Mckinzie DL. Muscarinic mechanisms of antipsychotic atypicality. Prog Neuropsycho-pharmacol Biol Psychiatry . 2003;27(7):1125–1143. doi: 10.1016/j.pnpbp.2003.09.008 PMID: 14642972</mixed-citation></citation-alternatives></ref><ref id="cit136"><label>136</label><citation-alternatives><mixed-citation xml:lang="ru">Marinelli C, Bertalot T, Zusso M, Skaper SD, Giusti P. Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage. Front Cell Neurosci. 2016;10:27. doi: 10.3389/fncel.2016.00027</mixed-citation><mixed-citation xml:lang="en">Marinelli C, Bertalot T, Zusso M, Skaper SD, Giusti P. Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage. Front Cell Neurosci. 2016;10:27. doi: 10.3389/fncel.2016.00027</mixed-citation></citation-alternatives></ref><ref id="cit137"><label>137</label><citation-alternatives><mixed-citation xml:lang="ru">Choi MH, Na JE, Yoon YR, Lee HJ, Yoon S, Rhyu IJ, Baik JH. Role of Dopamine D2 Receptor in Stress-Induced Myelin Loss. Sci Rep. 2017;7(1):11654. doi: 10.1038/s41598-017-10173-9 Erratum in: Sci Rep. 2018;8(1):6055.</mixed-citation><mixed-citation xml:lang="en">Choi MH, Na JE, Yoon YR, Lee HJ, Yoon S, Rhyu IJ, Baik JH. Role of Dopamine D2 Receptor in Stress-Induced Myelin Loss. Sci Rep. 2017;7(1):11654. doi: 10.1038/s41598-017-10173-9 Erratum in: Sci Rep. 2018;8(1):6055.</mixed-citation></citation-alternatives></ref><ref id="cit138"><label>138</label><citation-alternatives><mixed-citation xml:lang="ru">Pani L, Porcella A, Gessa GL. The role of stress in the pathophysiology of the dopaminergic system. Mol Psychiatry. 2000;5(1):14–21. doi: 10.1038/sj.mp.4000589</mixed-citation><mixed-citation xml:lang="en">Pani L, Porcella A, Gessa GL. The role of stress in the pathophysiology of the dopaminergic system. Mol Psychiatry. 2000;5(1):14–21. doi: 10.1038/sj.mp.4000589</mixed-citation></citation-alternatives></ref><ref id="cit139"><label>139</label><citation-alternatives><mixed-citation xml:lang="ru">Bongarzone ER, Howard SG, Schonmann V, Campagnoni AT. Identification of the dopamine D3 receptor in oligodendrocyte precursors: potential role in regulating differentiation and myelin formation. J Neurosci. 1998;18(14):5344–5353. doi: 10.1523/JNEUROSCI.18-14-05344.1998</mixed-citation><mixed-citation xml:lang="en">Bongarzone ER, Howard SG, Schonmann V, Campagnoni AT. Identification of the dopamine D3 receptor in oligodendrocyte precursors: potential role in regulating differentiation and myelin formation. J Neurosci. 1998;18(14):5344–5353. doi: 10.1523/JNEUROSCI.18-14-05344.1998</mixed-citation></citation-alternatives></ref><ref id="cit140"><label>140</label><citation-alternatives><mixed-citation xml:lang="ru">Todd RD. Neural development is regulated by classical neurotransmitters: dopamine D2 receptor stimulation enhances neurite outgrowth. Biol Psychiatry . 1992;31(8):794–807. doi: 10.1016/0006-3223(92)90311-m</mixed-citation><mixed-citation xml:lang="en">Todd RD. Neural development is regulated by classical neurotransmitters: dopamine D2 receptor stimulation enhances neurite outgrowth. Biol Psychiatry . 1992;31(8):794–807. doi: 10.1016/0006-3223(92)90311-m</mixed-citation></citation-alternatives></ref><ref id="cit141"><label>141</label><citation-alternatives><mixed-citation xml:lang="ru">Mitelman SA, Buchsbaum MS, Christian BT, Merrill BM, Buchsbaum BR, Mukherjee J, Lehrer DS. Dopamine receptor density and white mater integrity: F-fally-pride positron emission tomography and diffusion tensor imaging study in healthy and schizophrenia subjects. Brain Imaging Behav. 2020;14(3):736–752. doi: 10.1007/s11682-018-0012-0</mixed-citation><mixed-citation xml:lang="en">Mitelman SA, Buchsbaum MS, Christian BT, Merrill BM, Buchsbaum BR, Mukherjee J, Lehrer DS. Dopamine receptor density and white mater integrity: F-fally-pride positron emission tomography and diffusion tensor imaging study in healthy and schizophrenia subjects. Brain Imaging Behav. 2020;14(3):736–752. doi: 10.1007/s11682-018-0012-0</mixed-citation></citation-alternatives></ref><ref id="cit142"><label>142</label><citation-alternatives><mixed-citation xml:lang="ru">Hrvatin S, Hochbaum DR, Nagy MA, Cicconet M, Robertson K, Cheadle L, Zilionis R, Ratner A, Borges-Monroy R, Klein AM, Sabatini BL, Greenberg ME. Single-cell analysis of experience-dependent transcriptomic states in the mouse visual cortex. Nat Neurosci. 2018;21(1):120–129. doi: 10.1038/s41593-017-0029-5</mixed-citation><mixed-citation xml:lang="en">Hrvatin S, Hochbaum DR, Nagy MA, Cicconet M, Robertson K, Cheadle L, Zilionis R, Ratner A, Borges-Monroy R, Klein AM, Sabatini BL, Greenberg ME. Single-cell analysis of experience-dependent transcriptomic states in the mouse visual cortex. Nat Neurosci. 2018;21(1):120–129. doi: 10.1038/s41593-017-0029-5</mixed-citation></citation-alternatives></ref><ref id="cit143"><label>143</label><citation-alternatives><mixed-citation xml:lang="ru">Damiano S, La Rosa G, Sozio C, Cavaliere G, Trinchese G, Raia M, Paternò R, Mollica MP, Avvedimento VE, Santillo M. 5-Hydroxytryptamine Modulates Maturation and Mitochondria Function of Human Oligodendrocyte Progenitor M03-13 Cells. Int J Mol Sci. 2021;22(5):2621. doi: 10.3390/ijms22052621</mixed-citation><mixed-citation xml:lang="en">Damiano S, La Rosa G, Sozio C, Cavaliere G, Trinchese G, Raia M, Paternò R, Mollica MP, Avvedimento VE, Santillo M. 5-Hydroxytryptamine Modulates Maturation and Mitochondria Function of Human Oligodendrocyte Progenitor M03-13 Cells. Int J Mol Sci. 2021;22(5):2621. doi: 10.3390/ijms22052621</mixed-citation></citation-alternatives></ref><ref id="cit144"><label>144</label><citation-alternatives><mixed-citation xml:lang="ru">Fan LW, Bhatt A, Tien LT, Zheng B, Simpson KL, Lin RC, Cai Z, Kumar P, Pang Y. Exposure to serotonin adversely affects oligodendrocyte development and myelination in vitro. J Neurochem. 2015;133(4):532–543. doi: 10.1111/jnc.12988</mixed-citation><mixed-citation xml:lang="en">Fan LW, Bhatt A, Tien LT, Zheng B, Simpson KL, Lin RC, Cai Z, Kumar P, Pang Y. Exposure to serotonin adversely affects oligodendrocyte development and myelination in vitro. J Neurochem. 2015;133(4):532–543. doi: 10.1111/jnc.12988</mixed-citation></citation-alternatives></ref><ref id="cit145"><label>145</label><citation-alternatives><mixed-citation xml:lang="ru">Thoma s Broome S , L ouangaphay K , Keay K A , L egg io GM , Musumeci G, Castorina A. Dopamine: an immune transmitter. Neural Regen Res. 2020;15(12):2173– 2185. doi: 10.4103/1673-5374.284976</mixed-citation><mixed-citation xml:lang="en">Thoma s Broome S , L ouangaphay K , Keay K A , L egg io GM , Musumeci G, Castorina A. Dopamine: an immune transmitter. Neural Regen Res. 2020;15(12):2173– 2185. doi: 10.4103/1673-5374.284976</mixed-citation></citation-alternatives></ref><ref id="cit146"><label>146</label><citation-alternatives><mixed-citation xml:lang="ru">Channer B, Matt SM, Nickoloff-Bybel EA, Pappa V, Agarwal Y, Wickman J, Gaskill PJ. Dopamine, Immunity, and Disease. Pharmacol Rev . 2023;75(1):62–158. doi: 10.1124/pharmrev.122.000618</mixed-citation><mixed-citation xml:lang="en">Channer B, Matt SM, Nickoloff-Bybel EA, Pappa V, Agarwal Y, Wickman J, Gaskill PJ. Dopamine, Immunity, and Disease. Pharmacol Rev . 2023;75(1):62–158. doi: 10.1124/pharmrev.122.000618</mixed-citation></citation-alternatives></ref><ref id="cit147"><label>147</label><citation-alternatives><mixed-citation xml:lang="ru">McKenna F, McLaughlin PJ, Lewis BJ, Sibbring GC, Cummerson JA, Bowen-Jones D, Moots RJ. Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study. J Neuroimmunol. 2002;132(1– 2):34–40. doi: 10.1016/s0165-5728(02)00280-1</mixed-citation><mixed-citation xml:lang="en">McKenna F, McLaughlin PJ, Lewis BJ, Sibbring GC, Cummerson JA, Bowen-Jones D, Moots RJ. Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study. J Neuroimmunol. 2002;132(1– 2):34–40. doi: 10.1016/s0165-5728(02)00280-1</mixed-citation></citation-alternatives></ref><ref id="cit148"><label>148</label><citation-alternatives><mixed-citation xml:lang="ru">Pacheco R. Targeting dopamine receptor D3 signalling in inflammation. Oncotarget. 2017;8(5):7224– 7225. doi: 10.18632/oncotarget.14601</mixed-citation><mixed-citation xml:lang="en">Pacheco R. Targeting dopamine receptor D3 signalling in inflammation. Oncotarget. 2017;8(5):7224– 7225. doi: 10.18632/oncotarget.14601</mixed-citation></citation-alternatives></ref><ref id="cit149"><label>149</label><citation-alternatives><mixed-citation xml:lang="ru">Elgueta D, Aymerich MS, Contreras F, Montoya A, Celorrio M, Rojo-Bustamante E, Riquelme E, González H, Vásquez M, Franco R, Pacheco R. Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson’s disease. Neuropharmacology. 2017;113(PtA):110–123. doi: 10.1016/j.neuropharm.2016.09.028</mixed-citation><mixed-citation xml:lang="en">Elgueta D, Aymerich MS, Contreras F, Montoya A, Celorrio M, Rojo-Bustamante E, Riquelme E, González H, Vásquez M, Franco R, Pacheco R. Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson’s disease. Neuropharmacology. 2017;113(PtA):110–123. doi: 10.1016/j.neuropharm.2016.09.028</mixed-citation></citation-alternatives></ref><ref id="cit150"><label>150</label><citation-alternatives><mixed-citation xml:lang="ru">Hodo TW, Prudente de Aquino MT, Shimamoto A, Shanker A. Critical Neurotransmitters in the Neuroimmune Network. Front Immunol. 2020;11:1869. doi: 10.3389/fimmu.2020.01869</mixed-citation><mixed-citation xml:lang="en">Hodo TW, Prudente de Aquino MT, Shimamoto A, Shanker A. Critical Neurotransmitters in the Neuroimmune Network. Front Immunol. 2020;11:1869. doi: 10.3389/fimmu.2020.01869</mixed-citation></citation-alternatives></ref><ref id="cit151"><label>151</label><citation-alternatives><mixed-citation xml:lang="ru">Vidal PM, Pacheco R.The Cross-Talk Between the Dopaminergic and the Immune System Involved in Schizophrenia. Front Pharmacol. 2020;11:394. doi: 10.3389/fphar.2020.00394</mixed-citation><mixed-citation xml:lang="en">Vidal PM, Pacheco R.The Cross-Talk Between the Dopaminergic and the Immune System Involved in Schizophrenia. Front Pharmacol. 2020;11:394. doi: 10.3389/fphar.2020.00394</mixed-citation></citation-alternatives></ref><ref id="cit152"><label>152</label><citation-alternatives><mixed-citation xml:lang="ru">Brito-Melo GE, Nicolato R, de Oliveira AC, Menezes GB, Lélis FJ, Avelar RS, Sá J, Bauer ME, Souza BR, Teixeira AL, Reis HJ. Increase in dopaminergic, but not serotoninergic, receptors in T-cells as a marker for schizophrenia severity. J Psychiatr Res. 2012;46(6):738– 742. doi: 10.1016/j.jpsychires.2012.03.004</mixed-citation><mixed-citation xml:lang="en">Brito-Melo GE, Nicolato R, de Oliveira AC, Menezes GB, Lélis FJ, Avelar RS, Sá J, Bauer ME, Souza BR, Teixeira AL, Reis HJ. Increase in dopaminergic, but not serotoninergic, receptors in T-cells as a marker for schizophrenia severity. J Psychiatr Res. 2012;46(6):738– 742. doi: 10.1016/j.jpsychires.2012.03.004</mixed-citation></citation-alternatives></ref><ref id="cit153"><label>153</label><citation-alternatives><mixed-citation xml:lang="ru">Boneberg EM, von Seydlitz E, Pröpster K, Watzl H, Rockstroh B, Illges H. D3 dopamine receptor mRNA is elevated in T cells of schizophrenic patients whereas D4 dopamine receptor mRNA is reduced in CD4 + -T cells. J Neuroimmunol. 2006;173(1–2):180–187. doi: 10.1016/j.jneuroim.2005.11.018</mixed-citation><mixed-citation xml:lang="en">Boneberg EM, von Seydlitz E, Pröpster K, Watzl H, Rockstroh B, Illges H. D3 dopamine receptor mRNA is elevated in T cells of schizophrenic patients whereas D4 dopamine receptor mRNA is reduced in CD4 + -T cells. J Neuroimmunol. 2006;173(1–2):180–187. doi: 10.1016/j.jneuroim.2005.11.018</mixed-citation></citation-alternatives></ref><ref id="cit154"><label>154</label><citation-alternatives><mixed-citation xml:lang="ru">Mancini M, Natoli S, Gardoni F, Di Luca M, Pisani A. Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19. Int J Mol Sci . 2023;24(6):5618. doi: 10.3390/ijms24065618</mixed-citation><mixed-citation xml:lang="en">Mancini M, Natoli S, Gardoni F, Di Luca M, Pisani A. Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19. Int J Mol Sci . 2023;24(6):5618. doi: 10.3390/ijms24065618</mixed-citation></citation-alternatives></ref><ref id="cit155"><label>155</label><citation-alternatives><mixed-citation xml:lang="ru">Felger JC, Miller AH. Cytokine effects on the basal ganglia and dopamine function: The subcortical source of inflammatory malaise. Front. Neuroendocrinol . 2012;33:315–327. doi: 10.1016/j.yfrne.2012.09.003</mixed-citation><mixed-citation xml:lang="en">Felger JC, Miller AH. Cytokine effects on the basal ganglia and dopamine function: The subcortical source of inflammatory malaise. Front. Neuroendocrinol . 2012;33:315–327. doi: 10.1016/j.yfrne.2012.09.003</mixed-citation></citation-alternatives></ref><ref id="cit156"><label>156</label><citation-alternatives><mixed-citation xml:lang="ru">Quintero-Villegas A, Valdés-Ferrer SI. Role of 5-HT receptors in the immune system in health and disease. Mol Med. 2019;26(1):2. doi: 10.1186/s10020-019-0126-x</mixed-citation><mixed-citation xml:lang="en">Quintero-Villegas A, Valdés-Ferrer SI. Role of 5-HT receptors in the immune system in health and disease. Mol Med. 2019;26(1):2. doi: 10.1186/s10020-019-0126-x</mixed-citation></citation-alternatives></ref><ref id="cit157"><label>157</label><citation-alternatives><mixed-citation xml:lang="ru">Krabbe G, Matyash V, Pannasch U, Mamer L, Boddeke HW, Kettenmann H. Activation of serotonin receptors promotes microglial injury-induced motility but attenuates phagocytic activity. Brain Behav Immun . 2012;26(3):419–428. doi: 10.1016/j.bbi.2011.12.002</mixed-citation><mixed-citation xml:lang="en">Krabbe G, Matyash V, Pannasch U, Mamer L, Boddeke HW, Kettenmann H. Activation of serotonin receptors promotes microglial injury-induced motility but attenuates phagocytic activity. Brain Behav Immun . 2012;26(3):419–428. doi: 10.1016/j.bbi.2011.12.002</mixed-citation></citation-alternatives></ref><ref id="cit158"><label>158</label><citation-alternatives><mixed-citation xml:lang="ru">Mahé C, Loetscher E, Dev KK, Bobirnac I, Otten U, Schoeffter P. Serotonin 5-HT7 receptors coupled to induction of interleukin-6 in human microglial MC-3 cells. Neuropharmacology. 2005;49(1):40–47. doi: 10.1016/j.neuropharm.2005.01.025</mixed-citation><mixed-citation xml:lang="en">Mahé C, Loetscher E, Dev KK, Bobirnac I, Otten U, Schoeffter P. Serotonin 5-HT7 receptors coupled to induction of interleukin-6 in human microglial MC-3 cells. Neuropharmacology. 2005;49(1):40–47. doi: 10.1016/j.neuropharm.2005.01.025</mixed-citation></citation-alternatives></ref><ref id="cit159"><label>159</label><citation-alternatives><mixed-citation xml:lang="ru">Turkin A, Tuchina O, Klempin F. Microglia Function on Precursor Cells in the Adult Hippocampus and Their Responsiveness to Serotonin Signaling. Front Cell Dev Biol. 2021;9:665739. doi: 10.3389/fcell.2021.665739</mixed-citation><mixed-citation xml:lang="en">Turkin A, Tuchina O, Klempin F. Microglia Function on Precursor Cells in the Adult Hippocampus and Their Responsiveness to Serotonin Signaling. Front Cell Dev Biol. 2021;9:665739. doi: 10.3389/fcell.2021.665739</mixed-citation></citation-alternatives></ref><ref id="cit160"><label>160</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
